Portland State University

PDXScholar
Dissertations and Theses

Dissertations and Theses

7-7-2022

Treatment Disparities in Emergency Medical
Services: The Influence of Race/Ethnicity, Obesity,
and English Proficiency
Jamie Wayne Kennel
Portland State University

Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds
Part of the Medicine and Health Commons

Let us know how access to this document benefits you.
Recommended Citation
Kennel, Jamie Wayne, "Treatment Disparities in Emergency Medical Services: The Influence of Race/
Ethnicity, Obesity, and English Proficiency" (2022). Dissertations and Theses. Paper 6023.
https://doi.org/10.15760/etd.7894

This Dissertation is brought to you for free and open access. It has been accepted for inclusion in Dissertations
and Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more
accessible: pdxscholar@pdx.edu.

Treatment Disparities in Emergency Medical Services:
The Influence of Race/Ethnicity, Obesity, and English Proficiency

by
Jamie Kennel

A dissertation submitted in partial fulfillment of the
requirements for the degree of

Doctor of Philosophy
in
Sociology

Dissertation Committee:
Hyeyoung Woo, Chair
Ginny Garcia-Alexander
Matthew J. Carlson
Maura Kelly
Liu-Qin Yang

Portland State University
2022

Abstract
Different treatment in healthcare settings provided to different social groups of
people may lead to disparities in health, quality of life, and life span. Despite the critical
role among healthcare services that Emergency Medical Services (EMS) provides
disproportionately for marginalized communities, it remains unclear if and to what extent
treatment disparities take place in the pre-hospital setting. Guided by the theoretical
frameworks of social worth, aversive racism, and stigma, this study utilizes medical chart
data from three different public and private datasets to investigate treatment disparities by
Emergency Medical Service providers for racial minority, obese, and limited English
proficiency patients. While controlling for various confounders, three primary findings
are revealed: (1) all racial minority patients received a lower quality of EMS treatment;
(2) obesity status conferred a treatment advantage for men and a disadvantage for
women; and (3) patients who are not fluent in English received a reduced quality of EMS
treatment. These findings are largely aligned with the existing theories, signifying the
critical role that social characteristics have in influencing the quality of treatment in
EMS. Moreover, the findings provide important clinical practice and policy implications.
Limitations of the study are acknowledged and future research directions are discussed.
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Chapter 1. Introduction
1-1

Problem Statement
Disparities in health between populations produce concordant disparities in

quality of life and life span. While an individual’s health status is influenced by genetic
susceptibilities (or advantages), it is also considerably influenced by various social
factors, such as race, gender, socio-economic status, and the quality of medical care
received. Despite awareness of societally-driven disparities in health, these inequities
have persisted for decades (Marmot et al. 1991; Phelan et al. 2004).
In the US, a substantial proportion of the population is uninsured, creating barriers
to obtaining treatment, which can lead directly to health disparities. However, even
among those who have access to healthcare services, the quality of treatment received is
often influenced by a patient’s social characteristics (McKinlay, Potter, and Feldman
1996; Schulman et al. 1999; Smedley, Stith, and Nelson 2003; US Department of Health
and Human Services 2018). The Institute of Medicine published “Unequal Treatment”
almost twenty years ago, a seminal report outlining several of the ways in which
racial/ethnic minority patients are more likely to receive a lower quality of healthcare
compared to white patients, even when controlling for access factors such as insurance
status, income, and geographic location (Smedley et al. 2003). Of course, race and
ethnicity are not the only social factors that can influence the quality of healthcare
treatments. For example, prior studies have shown that patients perceived as obese and
those with limited English proficiency (LEP) are also more likely to receive lower quality
of healthcare, compared to non-obese patients and patients who are proficient in English
1

(Gandhi et al. 2000; Kirkman-Liff and Mondragon 1991; Marcos et al. 1973; Marks et al.
1987; Phelan et al. 2015; Woloshin et al. 1997).
Race/Ethnicity, Obesity Status, and Patients with Limited English Proficiency
Racial minorities are more likely to receive lower quality medical care in the
United States when compared to white patients. While not all medical specialties have
been investigated, previous research found consistent evidence of racial/ethnic treatment
disparities in cardiovascular care, cancer diagnostics, cancer treatment, HIV treatment,
diabetes treatment, end-stage renal disease, pediatric care, mental health services, and
amputations, among other treatments and procedures (Smedley et al. 2003), along with a
few studies with conflicting findings (Fuentes, Kohn, and Neighbor 2002; Nafiu et al.
2017).
Additionally, individuals with obesity are also more likely to receive substandard
medical treatment, compared to non-obese individuals when they engage healthcare in
the US (Budd GM, Mariotti M, Graff D 2009; S. M. Phelan et al. 2014; Teachman and
Brownell 2001; Wee, Phillips, and McCarthy 2005). There is also substantial stigma
associated with being labeled as obese that has a direct, significant, and independent
impact on morbidity and mortality (Di Angelantonio et al. 2016; Manson et al. 1995;
Visscher and Seidell 2001). From a healthcare service perspective, there are several
reasons why more attention is needed to address healthcare disparities for individuals
with obesity. First, those who are obese are more vulnerable to serious health concerns
(such as cardiovascular disease, type 2 diabetes, various respiratory disorders, several
cancers, osteoporosis, and gall bladder disease). Second, individuals with obesity are
2

more likely to experience more severe complications and consequences from these
conditions (Manson et al. 1995; Visscher and Seidell 2001). Third, and as a direct result
of the above, individuals with obesity utilize healthcare services more frequently.
Considering that rates of obesity in the US have increased rapidly over the last 20 years
(Rubenstein 2005; Yang and Colditz 2015), understanding treatment disparities
experienced by obese patients is especially critical to improve public health.
Finally, in the United States, individuals who are not proficient English speakers
have increased by 80% in the last 20 years, currently comprising 8.5% of the total
population. The ability to effectively communicate with a patient is foundational to
providing quality medical care. Communication between a provider and a patient is
needed to effectively understand a patient’s complaint, discuss treatment options, obtain
informed consent, as well as to communicate newly diagnosed medical conditions and
the importance of adherence to treatment protocols (Ratna 2019). When medical
providers are unable to speak the same language as the patient, the quality of their
medical treatment is negatively impacted in several ways, including increased cancelation
rates of preventative health appointments, increased rates of hospital discharges against
medical advice (AMA), and an increased likelihood of dangerous medication interactions
(Gandhi et al. 2000; Marcos et al. 1973; Marks et al. 1987).

1-2

Problem Importance
The research presented here is centered on examining treatment disparities in

EMS for four primary reasons. First, despite the high number of patients utilizing EMS,
3

potential treatment disparities in EMS remain underexplored with very few published
studies investigating racial disparities, and no research to our knowledge exploring EMS
treatment disparities for obese patients or LEP patients (Hewes et al. 2017; Young et al.
2013). Second, marginalized populations are more likely to use EMS services for their
healthcare needs. A recent study reported that adult EMS utilization rates for all types of
medical and traumatic emergencies are higher in poor neighborhoods, among racial
minority neighborhoods, and in neighborhoods with higher rates of residents whom are
currently non-US citizens, compared to high socioeconomic neighborhoods,
neighborhoods that are predominantly white, and neighborhoods with higher rates of
individuals who are currently US citizens, respectively (Seim, English, and Sporer 2017).
Third, the quality of EMS medical treatment can have direct morbidity and mortality
consequences for an individual. Many medical or traumatic emergencies that EMS is
called to provide treatment for have life and death consequences, such as heart attacks,
strokes, amputations, respiratory failure, chokings, etc. In these situations, among others,
treatment disparities can lead directly to a patient’s preventable death or lifelong chronic
health conditions with a host of enduring negative impacts. Fourth, the influence of nonmedical social factors for treatment decisions may be greater in EMS. EMS providers
operate in dynamic field-based settings (outside of a hospital or clinic) where medical
decisions are often made under time pressure and/or with incomplete information, both
conditions which have been shown to be more likely to result in treatment disparities in
other similar areas of medicine (Burgess 2010; Burgess et al. 2014).

4

1-3

Theoretical Guidance
Social Worth Theory (Glaser and Strauss 1964; Roth 1972; Sudnow 1967)

provides a theoretical framework from which to understand how and in which
circumstances a patient’s social characteristics is most likely to lead to discriminatory
medical treatment. Social Worth Theory (SWT) posits that in medical settings a patient’s
perceived worth to society, as determined by their social characteristics, influences the
quality of treatment provided by the medical team. A patient’s social worth, according to
the theory, is constructed through two stages; (1) development of personhood (versus an
anonymous Jane/John Doe), and (2) attributing cultural characteristics to the person
through the creation of the patient’s ‘social loss story.’ SWT was originally developed
through ethnographic studies of the treatment of cardiac arrest patients in Emergency
Departments, and the framework of a ‘social loss story’ was proposed as useful in
understanding both the level of treatment provided to the patient as well as the degree to
which the medical staff would be expected to grieve the potential death of the patient.
The theory suggests personhood status achievement in medical environments is
influenced by two primary criteria: (1) anonymity status; and (2) association with positive
social characteristics. Anonymity status is determined either initially through a member
of the medical team recognizing the patient or, over the time when the patient is in the
medical team’s care, through direct patient communication (as available), communication
with family or friends if present, or from patient identification found on the patient’s
belongings that establishes the patient as either a specifically recognizable member of the

5

community or someone deemed to fulfill a socially ‘respectable’ role in society (e.g.,
father, mother, CEO, police officer).
If personhood status, as perceived by the medical staff, is not achieved and the
patient is deemed anonymous (aka Jane/John Doe), a patient’s social loss story is often
not developed, and social attributes considered positive by the medical staff that are
learned about the anonymous patient are less likely to be seen as valid when compared to
patients who did reach personhood status. Further, the medical team’s efforts to identify
information that may result in achieving personhood status for a patient is truncated for
individuals deemed to have made morally offensive behavior choices such as patients
appearing altered from drugs or alcohol, smelling of foul odors, or appear to work in
morally devalued occupations, such as prostitution (especially for women).
If personhood status is achieved, a social loss story is theorized to be created
through (1) social characteristics, (2) interaction characteristics, and (3) patient
legitimacy determination. First, social characteristics are collected by medical personnel
from both apparent and learned social features at the initial patient encounter. Apparent
social features are quickly determined from a patient’s outwardly observable features
such as age, race, gender, weight, physical appearance, and vernacular. Additionally, if
sufficient time and patient responsiveness allows for patient interaction during the
medical encounter, learned social features such as the patient’s occupation, education,
family status, among other characteristics, are collected. The summation of these social
features comprises a significant portion of the ‘social loss story’ or social worth of the
patient.
6

Second, once a patient’s social characteristics are collected, the patient’s features
that result from interacting with the medical providers are evaluated and incorporated into
the patient’s social loss story. Here too there are observed features as well as interactive
features that contribute. Social worth theory suggests that observed features that are
discovered during interactions such as having a foul odor, being perceived as dirty,
having a presumed infectious condition (e.g., parasites or viral/bacterial agents), or
patients believed to be carrying weapons or needles can increase the negative value of the
social loss story. If direct patient communication is possible, the patient is then further
evaluated on how well they defer to medical authority as judged by how pleasantly they
cooperate with the medical staff and accept recommended medical treatments.
Third, a patient’s legitimacy is evaluated by medical providers. According to the
theory, a patient’s legitimacy is appraised based on three key criteria which provide
opportunities to both enhance and detract from the patient’s overall social worth. First,
the medical provider assesses if the patient’s medical condition is deemed appropriate or
suitable for the medical specialty that the patient is requesting help from. While this
criterion seems relatively simple when considering medical specialties that are focused
on specific anatomical systems (e.g., patients suffering from a heart attack are deemed
legitimate patients for the cardiology service), other specialties that are not based on
anatomical systems but instead are largely time based (e.g., emergency medicine) present
a high degree of subjectivity regarding what constitutes appropriate use. Second, the
authenticity or believability of the patient’s condition as perceived by the medical
provider is considered and the more believable or authentic the condition, the higher the
7

patient’s perceived worth. While some medical conditions have highly sensitive and
specific assessment tests to objectively determine the validity of the patient’s complaint
(e.g., elevated troponin levels as a clear sign of a heart attack), others lack sensitive and
specific assessment capabilities, commonly resulting in an inability to make a confident
diagnosis (e.g., atraumatic abdominal pain, fibromyalgia). It is in these subjective
conditions where the patient’s perceived truthfulness is most scrutinized. Third, the more
the medical provider finds the patient’s condition medically interesting the more it is
valued. What is deemed to be medically interesting varies across the type of institution
(e.g., a teaching hospital versus a critical access hospital) and changes over time as novel
and interesting presentations and conditions can become routine as they become more
frequent.
The complex, but not always conscious, calculus of determining a patient’s social
worth, is assembled through social, interaction, and legitimacy characteristics, and serves
to influence the medical decision-making process regarding the quality of healthcare
provided to the patient. While SWT provides an overarching framework to better
understand differing levels of medical treatment for equivalent patient conditions,
additional theoretical frameworks will be introduced in the following chapters to provide
further clarity on how race/ethnicity (Aversive Racism Theory) and obesity (Stigma
Theory) function within the SWT framework.

1-4

Research Problems

8

This dissertation investigates three primary research questions. (1) Do racial
minorities, compared to white individuals, receive less treatment when receiving care
from EMS providers? (2) Are patients classified as obese, compared to patients without
obesity, more likely to receive less treatment when receiving care from EMS providers?
And: (3) do patients with limited English proficiency, compared to patients who are
proficient in English, receive less treatment when receiving care from EMS providers?
To address these questions, I adjust for confounding social characteristics to more
accurately estimate the influences of race/ethnicity, obesity status, and LEP status on
treatment disparities in EMS.

1-5

Purpose of the Study
The purpose of this study is to examine several social factors associated with the

amount of medical care provided by EMS, focusing on the effects that a patient’s
race/ethnicity, obesity status, and LEP status have on the treatment received.

1-6

Contributions and Significance
This study has two primary contributions. First, the results of this work contribute

to the growing body of knowledge on healthcare treatment disparities by increasing our
understanding of the roles that the patient characteristics of race/ethnicity, obesity, and
LEP have in treatment disparities in EMS. Second, the findings from this research may be
useful in evaluating the implications of various policies and procedures, which could
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have immediate impacts on reducing health disadvantages among racial minorities, obese
individuals, and those who have LEP.
I utilize three separate datasets of EMS medical charts for this research: one
publicly available and two private datasets. The first data set is the publicly available
Oregon Emergency Medical Services Information System dataset, consisting of patient
medical charts from a majority of the EMS agencies providing patient care in Oregon. To
allow a more robust exploration of obesity and LEP treatment disparities, I utilize two
private datasets to explore these research questions: one from the EMS ambulance
provider American Medical Response (AMR) in Multnomah County, Oregon and the
second, AMR in Clark County, which provides ambulance service for the City of
Vancouver, Washington.
Chapter 2. Race and Treatment Disparities in EMS
This chapter has been published, in part, as: Kennel J., Withers E., Parsons N.,
Woo H. Racial/Ethnic Disparities in Pain Treatment Evidence from Oregon Emergency
Medical Services Agencies. Medical Care. 2019, 57(12):924-929.

2-1

Introduction
In the US, when compared to White patients, racial/ethnic minorities are more

likely to receive lower quality medical care across many areas of medicine (AHRQ 2016;
Smedley et al. 2003). While there are a few exceptions (Fuentes et al. 2002; Nafiu et al.
2017), previous studies have documented evidence describing the presence and severity
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of racial/ethnic treatment disparities in numerous specialties of medical practice (e.g.,
Emergency Medicine, Cardiology, Oncology).
However, racial/ethnic treatment disparities in the field of Emergency Medical
Services (EMS) remains relatively less examined than other fields of medicine despite its
importance (Institute of Medicine 2007). Emergency Medical Services treats an estimated
16 million sick and injured individuals annually, often with acute morbidity and mortality
consequences. Moreover, EMS may be a more important source of healthcare for
racial/ethnic minorities, as they rely on EMS more frequently than their White
counterparts (Seim et al. 2017; Shah et al. 2008; Tataris, Kivlehan, and Govindarajan
2014).

2-2

Empirical Evidence
To my knowledge, only two published studies have investigated racial/ethnic

disparities in the EMS treatment of pain. First, Young et al. (2013) investigated the use of
morphine in blunt trauma calls for adults in a single EMS system in Contra Costa County,
CA, and found that Black patients were half as likely to receive morphine compared to
White patients when a pain score was documented (Young et al. 2013). This finding is
consistent with evidence of racial/ethnic treatment disparities found in previous studies of
Emergency Department pain treatment (Mills et al. 2011; Todd 1993; Todd et al. 1999)
More recently, considering patient race/ethnicity as a risk factor in select
traumatic injuries (fracture, burns, and penetrating trauma), Hewes et al. (2018) found
that all racial/ethnic minority adult patients received pain medications less often than
11

White patients even after controlling for the presence of pain as a documented symptom.
Further, they found evidence that children (< 15 years of age) who were charted as
racial/ethnic minorities received pain medications less often, with 10.9% of Black
children receiving pain medications compared to 25% of White children (Hewes et al.
2018).
Although these studies report important findings regarding racial/ethnic
disparities in EMS treatment, they are largely descriptive in nature and did not
incorporate confounding factors in their analysis. As a result, it is still not clear to what
extent patient race/ethnicity is associated with pain management in EMS when other
factors are adjusted for. For example, a patient’s socioeconomic status (SES) is an
important factor to consider for the analysis. It is well known that patients with lower
SES are more likely to receive a lower quality of medical care (Ver Ploeg and Perrin
2004; Roth 1972; Timmermans 1998; Williams, Priest, and Anderson 2016). More
importantly, given that racial/ethnic minorities are disproportionately represented at
lower SES levels compared to Whites, without adjusting for SES, it is unclear from both
prior studies the extent to which the observed disparities in the likelihood of receiving
pain medications is attributed to patient race/ethnicity.

2-3

Theoretical Guidance
While social worth theory, described earlier, details the mechanisms within

healthcare settings through which a medical team incorporates a patient’s cultural or
social characteristics in shaping the quality of their treatment, it provides little specificity
12

as to the critical role race plays in this framework. To provide further theoretical
guidance on how race impacts medical treatments, I utilize the theory of Aversive Racism
(Dovidio and Gaertner 2004) and its application to medical treatment settings (Whaley
1998).
Aversive Racism posits that individuals who are explicitly egalitarian (and wish
to be perceived that way) may still harbor conflicting negative feelings and beliefs, often
unconsciously, regarding racial minorities that result in disadvantaging racial minority
groups (Dovidio and Gaertner 2004). Importantly, this theory is not suggesting that the
negative associations that, for example, white individuals have of Black individuals in
society have been lessened or reduced. Instead it proposes that as racist beliefs have
shifted from being largely overt to being covert, the process of identifying racism has
become more complex, and it provides a framework to predict the situations in which
racial discrimination is more likely to manifest.
The theory of Aversive Racism attempts to account for the discrepancy between
the significant overt support for racial equity and the clear and substantial evidence of
persistent racial inequity, including the widely known disparities in education, housing,
criminal justice system, employment, and healthcare.
The theory suggests that because of an internal conflict taking place between an
individual’s conscious and unconscious beliefs, as well as the desire to minimize being
seen as prejudiced, individuals are more likely to express racial bias or discrimination in
situations where internal and external conflict are minimized. Therefore, in inter-racial
social situations where social norms are clearly established, discriminatory behaviors are
13

not as likely to manifest. This is in contrast to situations where guidelines of appropriate
behavior are vague or ambiguous, or in contexts where the normative social structure is
weak, where prejudiced behaviors are proposed to be more likely to manifest.
Aversive Racism posits that there are predictable and characterizable interaction
contexts in which racial bias and discrimination are theorized to be much more likely to
be expressed, which can be useful in identifying situations where a patient’s race may be
a particularly salient factor in influencing the patient’s medical care. In fact, prior to the
articulation of Aversive Racism, Whaley (1998) described four criteria to evaluate
characteristics of medical encounters that are more likely to result in discriminatory
treatments that are in alignment with the characteristics predicted by Aversive Racism.
The first criteria is the degree to which characteristics for identifying outgroup
membership are readily apparent. Second is the extent to which information that may
help to further individuate a patient is absent or difficult to obtain. The third examines if
the motives of the patient seeking treatment are vague or unclear, either perceived
through implied intent of the patient (e.g., limited or terse communication) or the patient
being in an unresponsive state due to their medical condition. Finally, the fourth criteria
are the extent to which the medical provider has relatively unrestrained options to guide
their interaction with the patient. Aversive racism as applied to medical encounters
suggests that racial discrimination is more likely to take place in the intersection of these
four characteristics and will be used to guide this research effort.
In summary, social worth theory provides guidance as to how medical providers
use social characteristics to create a patient’s social loss story, which in turn influences
14

the quality of medical care received, aligning with the social stratification observed in
society at large. The theory of aversive racism as applied to medical treatment provides a
model which can be used to identify the clinical situations in which racial discrimination
is most likely to exert influence on medical care. When considered together, these two
theories suggest that racial treatment disparities take place, and are more likely to take
place, when certain patient and clinical circumstances are present.

2-4

Research Question and Hypothesis
In the present study, we evaluate the equity of pain treatment practices for

traumatic and painful conditions by race/ethnicity using data from the Oregon Emergency
Medical Services Information System (OREMSIS). The current study is designed to
extend the existing literature in two important ways. First, in order to better capture the
effect of patient race/ethnicity on pain treatment practice, we incorporate several
additional variables as controls, such as patient insurance status, pain assessment
procedure, pain severity scores, and the EMS medical providers primary impression of
the injury or pain into multivariate models, which have not been considered in previous
studies. Second, we examine two outcome variables: (1) pain assessment, (2)
administration of a pain medication to improve visibility to potential racial/ethnic
treatment disparities. To address these research questions, I tested the following
hypotheses:

15

H1

Racial minority patients, compared to white patients, are less likely to receive a

pain assessment when being treatment by EMS providers for a traumatic injury.

H2

Racial minority patients, compared to white patients, are less likely to receive

pain medications when being treatment by EMS providers for a traumatic injury.

2-5

Data, Measures, and Methods

2-5-1 Data
This study utilizes data from the Oregon Emergency Medical Services
Information System (OREMSIS). The OREMSIS dataset consists of EMS patient care
reports (PCRs) uploaded by participating EMS agencies in Oregon. A PCR, typically
authored by the primary EMS medical provider, represents the official medical chart
document for the entire patient encounter, including all assessment findings, diagnoses,
and treatment interventions performed. Once the PCR is complete, the data elements are
standardized and normalized according to the OREMSIS technical requirements and
uploaded to the OREMSIS system where it becomes available for a variety of
surveillance, quality assurance, and research purposes. The OREMSIS dataset represents
the largest dataset of EMS PCRs in Oregon with over 15,000 PCRs added monthly from
an estimated 70% of EMS transporting agencies in Oregon (Anon 2016).
The sample includes EMS PCRs from adult patients (> 17 years of age) with a
Primary Impression of Traumatic Injury from January 1, 2015 through December 31,
2017. The Primary Impression field in OREMSIS is defined as “the EMS provider’s
16

impression of the patient’s primary problem or most significant condition which led to
the management given to the patient (treatment, medications, or procedures)” (NEMSIS
2016). OREMSIS contains 28 distinct traumatic injury values, all of which were included
in the sample. The timeframe was selected to take advantage of increased EMS agency
enrollment as well as improved data validation and standardization procedures
implemented to the OREMSIS system on January 1, 2015.
Several selection criteria were applied in an attempt to restrict the analytical
sample to cases eligible to receive pain medications. First, cases treated by an EMS team
member not credentialed at the paramedic level were excluded. This limited the analysis
to calls where the EMS providers on scene had the ability to administer pain medications
and focused the analysis on the most common EMS staffing model in Oregon for
Advanced Life Support (ALS) EMS operations. Second, as most pain medications
provided by EMS agencies in Oregon are opioids (99% in this sample), cases with
symptoms consistent with common opioid contraindications including symptoms of
respiratory distress or altered mental status were excluded.(Daya et al. 2017) Finally,
cases that contained missing values for key variables were excluded, resulting in a final
analytical sample of 25,732 PCRs.

2-5-2 Measures
Two outcome variables were examined in this analysis. The first outcome is
whether a pain assessment procedure was documented. This information is coded to
indicate, dichotomously, if a pain score was included on the PCR (1 for yes; and 0
17

otherwise). The second outcome is whether the administration of a pain medication was
documented on the PCR (1 for yes; 0 otherwise). Pain medication values included
acetaminophen, ketorolac, fentanyl, morphine, hydromorphone, and ketamine. A
breakdown by the type of medication (severe vs. non-severe) was not possible due to an
insufficient number of cases.
The independent variable is patient race/ethnicity. The analytic sample is
composed of PCRs from two versions of the OREMSIS dataset (versions 2 and 3), which
allowed for patient race and ethnicity to be captured differently. For example, OREMSIS
version 2 allowed only one response for patient race from the following categories:
White, Black, Asian, Native American Indian, Hawaiian, Pacific Islander, Other, Not
Recorded, Not Known, and Not Applicable. OREMSIS version 2 also allowed one
response for ethnicity, recorded as either Hispanic (or Latino) or non-Hispanic.
OREMSIS version 3, however, groups race and ethnicity values into a single variable and
allows multiple race/ethnicity values to be selected for each patient. As with most studies
that utilize medical charts for analysis, it is unclear if, and in which cases, the medical
provider consults with the patient before selecting a race or ethnicity.
For this study, we first combined the race and ethnicity variables from OREMSIS
version 2 into a series of new variables that resulted in the following mutually exclusive
categories: Hispanic (any race), non-Hispanic White, non-Hispanic Black, non-Hispanic
Asian, non-Hispanic Native American, non-Hispanic Hawaiian or Other Pacific Islander,
non-Hispanic Other, and non-Hispanic Unknown. Then, the same categories were created
to include patient records from OREMSIS version 3. Patient records that contained
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multiple race/ethnicity values were recoded as “other” (0.1% of the total sample). For
both versions of OREMSIS used in this study, PCRs with race/ethnicity values of Not
Recorded, Not Known, Not Applicable, and missing values are recoded as Unknown
(25.2% of the sample). Patients coded as non-Hispanic Native American or non-Hispanic
Hawaiian or Other Pacific Islander were included in the Other race/ethnicity due to the
small number of cases (1.2% of the sample). For reporting simplicity, the term “nonHispanic” was removed from subsequent race/ethnicity references.
Several social and demographic control variables were incorporated to more
accurately estimate the effect the primary predictor variable (race/ethnicity) might have
on the outcome variables. Variables which capture other social determinants and have
been shown to influence medical treatment were used as controls, including patient
gender, patient age, patient health insurance status (as a proxy for the patient’s
socioeconomic status), and the urbanicity of where the EMS encounter occurred. More
specifically, patient gender was incorporated as a control with the OREMSIS values of
female, male, and unknown. Because our exploratory analysis revealed a non-linear
relationship between patient age and the dependent variables (results not shown, but
available upon request), a squared term of the age variable was also included. Finally, in
an effort to control for patient SES, health insurance was incorporated with the following
values: Private, Medicaid, Medicare, No Insurance, Government Insurance, and Other
Insurance. In similar studies that analyze medical charts, the use of a patient health
insurance status has been shown to be an effective proxy for a patient’s SES (Ver Ploeg
and Perrin 2004). Because the geographic area where the EMS encounter took place may
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also influence the relationship that patient race/ethnicity exerts on pain treatment, the 5digit zip code from the EMS scene was grouped into urban (zip codes less than 10 miles
from a city centroid with 40,000 people or more), rural (zip codes greater than 10 miles
from a city centroid with 40,000 people or more), frontier (counties with 6 or fewer
people per square mile), and unclassified categories as provided from the Oregon Office
of Rural Health were included in the regression models as separate dichotomous
variables.
Additionally, two clinical variables were included as controls. First, the EMS
provider’s Primary Impression values (i.e. the provider’s assessment of the patient’s
primary problem which led to the treatment: the working diagnosis) were incorporated in
the statistical models as 28 separate dichotomous measures to account for the possibility
that pain management practices may vary by the different type of traumatic injury (i.e.
pelvis injury versus ankle injury). This allows us to account for the potential that patients
of different races engage EMS services for different types of traumatic injuries, and to
examine the possibility that different traumatic injuries may have differing levels of pain
assessment and treatment from EMS providers. Next, both the presence of a pain
assessment (dichotomously) as well as the resulting pain score values (0-10) were
included as separate control variables (pain medication administration regression only) to
account for the potential that different racial groups might engage EMS for differing
average pain scores, thus confounding the relationship between a patient’s race/ethnicity
and the outcome variables. Many PCRs collected multiple pain scores, but only the initial
pain score was used for this analysis as it represents a more influential pain score in the
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decision-making process to administer pain medication. Third, given a non-linear
relationship between a patient’s pain score and the likelihood of receiving pain
medications (results not shown, but available upon request), a quadratic transformation of
pain score was also included.

2-5-3 Methods
First, we conducted a descriptive analysis to show demographic and clinical
characteristics of the sample stratified by race/ethnicity (Table 1 and 2). Next, we
estimated two sets of multivariable logistic regression models for pain assessment (Table
3) and pain medication (Table 4) in order to examine the role of patient race/ethnicity in
the dependent variables while adjusting for covariates.

2-6

Results

Sample Characteristics
We analyzed 25,732 EMS patient encounters with a traumatic injury in Oregon
over a two-year period (2015-2017). As summarized in Table 1, when compared to the
total sample, White patients were slightly older (mean, age; 61, 23 y), had higher
proportions of female patients (52.3%), private insurance (28.3%), and Medicare
insurance (32.1%). A pain assessment procedure was present for 44% of the sample with
essentially equal representation for Black (45.1%) and White (44.5%) patients, but a
smaller proportion for Hispanic (38.5%) and Asian patients (35.4%). Regarding pain
scores, Black patients reported a higher average pain score (mean, SD; 5.8, 3.0), as did
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Hispanics (5.1, 3.0) when compared to White (4.2, 3.1) patients. A higher proportion of
White patients (20.1%) received pain medications when compared to all racial/ethnic
minorities (13.9% of Black patients, 17.2% of Hispanic patients, and 14.2% of Asian
patients).
As summarized in Table 2, the majority of PCRs contained Primary Impression
values of Other/Unspecified. Where additional granularity in the Primary Impression
values were charted, most traumatic injury locations did not show bivariate evidence of
disparities in pain assessment or pain medication with a few exceptions. When compared
to White patients, a significantly smaller proportion of racial minorities received a pain
assessment for traumatic injuries to the head and hip/pelvis locations. Also, when
compared to White patients, a significantly smaller proportion of racial minorities
received pain medications for traumatic injuries to the upper extremities (35.1% for
White patients compared to 20.3% of racial minority patients).

Pain Assessment Results
Two logistic regression models (Table 2-3) were performed to explore the
relationship that patient race/ethnicity had on a pain assessment procedure (dichotomous)
with and without adjusting for confounders. In the baseline unadjusted model, Hispanic
patients were 22% less likely (OR 0.78, 95% CI 0.70 – 0.88) and Asian patients were
32% less likely (OR 0.68, 95% CI 0.57 – 0.82) to receive a pain assessment when
compared to White patients. The adjusted model in Table 3 controls for patient gender,
patient age, patient age squared, the geographic location of the EMS encounter (urban,
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rural, frontier), patient insurance status, and provider’s primary impressions. In this
model Hispanic patients were 21% less likely (OR 0.79, 95% CI 0.70 – 0.90), and Asian
patients were 31% less likely (OR 0.69, 95% CI 0.57 – 0.84) to have a charted pain
measurement procedure when compared to White patients.

Pain Medication Administration Results
Additionally, two logistic regression models (Table 2-4) were estimated to
examine the relationship between patient race/ethnicity and the administration of pain
medications (dichotomous) with and without adjusting for covariates. According to the
results of the baseline unadjusted model in Table 4, all racial minorities are less likely to
receive pain medications when compared to White patients. The adjusted model in Table
4 controls for patient gender, patient age, patient age squared, the geographic location of
the EMS encounter, patient insurance status, the EMS provider’s primary impression
values (dichotomously coded), a pain assessment procedure (dichotomous), the patient’s
charted pain score value, and the pain score squared value. Our results show that the
racial disparities are still found with the covariates included. For example, Black patients
were 32% less likely (OR 0.68, 95% CI 0.58– 0.79), Hispanic patients were 21% less
likely (OR 0.79, 95% CI 0.68 – 0.93), Asian patients were 24% less likely (OR 0.76, 95%
CI 0.59 – 0.99), and patients categorized as Other race/ethnicity were 41% less likely
(OR 0.59, 95% CI 0.44 – 0.78) to receive pain medications when compared to White
patients.

23

2-7

Discussion and Conclusion
Our study demonstrates that Hispanic patients as well as Asian patients were less

likely to receive a pain assessment compared to White patients. Moreover, our study also
reveals that patients from all racial and ethnic minority groups were less likely to receive
pain medications compared to White patients when receiving treatment from EMS
providers for traumatic injuries.
Compared to White patients, Black patients reported a 38% higher average pain
score (5.8 vs 4.2), and we found no evidence that Black patients received a pain
assessment any less frequently. However, they were 32% less likely to receive any pain
medications from EMS providers. Similar to Black patients, Hispanic patients reported a
21% higher average pain score (5.1 vs 4.2) compared to White patients. However,
Hispanic patients were not only 21% less likely to have their pain assessed, but also 21%
less likely to receive any pain medications from EMS providers. Different from Black
patients and Hispanic patients, Asian patients reported 5% lower average pain scores (4.0
vs 4.2) compared to White patients. However, similar to Hispanic patients, Asian patients
were 31% less likely to have their pain assessed, and were 24% less likely to receive any
pain medications from EMS providers when compared to White patients.
While prior studies have identified disparities in pain medication administration
by patient race/ethnicity in EMS, our study is the first analysis of racial/ethnic disparities
in EMS care for both pain assessment and pain medication administration in a multisystem database that also controls for confounders.
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Given the concurrence of our findings with the existing literature on racial/ethnic
disparities in other areas of medical care, and the serious implications for such practices
for patients, future research for suspected mechanisms is warranted to further tease out
treatment disparities across race and ethnicity. Previous research suggests that the
mechanisms driving racial/ethnic disparate treatment may operate at the patient, provider,
and institution levels (Smedley et al. 2003).
At the patient level, evidence suggests patients with limited English proficiency,
which is likely to be relevant to some racial/ethnic minority populations, receive a lower
quality medical treatment in the Emergency Department (as well as other specialties)
(Brach, Fraser, and Paez 2005). To date, the strategies that have been attempted to
overcome language barriers in the practice of EMS have largely been informal with
poorly understood efficacy (Tate 2015a; Tate et al. 2016). At the provider level, EMS
medical providers may have an understanding of the concept of race/ethnicity as a
biological construct instead of a social one. While it has been shown conclusively that
there are no medically significant biological differences between individuals of different
races/ethnicities, there is evidence that medical providers nevertheless believe
race/ethnicity to be a medically relevant factor and may be adjusting their clinical actions
accordingly (Roberts 2012). At the institution level, clinical situations that require
medical providers to perform under high levels of cognitive load have been shown to
create environments that are conducive to racial/ethnic treatment disparities through the
activation of heuristics and stereotypes, which are known to contain bias (Bonilla-Silva
2014; Burgess 2010; Burgess et al. 2014; Kovel 1970).
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Limitations and Suggestions for Future Research
This study is not without limitations. First, as described earlier, it utilizes a

retrospective sample of PCRs limited to participating EMS agencies, that, while
statewide and representing the largest dataset of EMS charts in Oregon, was not
generated randomly. EMS agencies in Oregon voluntarily contributed PCRs to the
OREMSIS dataset in the years studied which introduces the potential for selection bias.
Second, the unit of analysis in this dataset is event-based, not patient-based. Two
different EMS agencies involved in providing medical care for the same patient
encounter may each contribute their own independent PCR. However, it seems unlikely
that this limitation would alter our results regarding racial/ethnic disparities in significant
ways as potential duplicate patient encounters are not limited to racial/ethnic minorities
only. Third, the input source for race/ethnicity values in the PCR is unspecified. As with
many investigations using race/ethnicity data from medical charts, it is unknown if the
patient’s race/ethnicity value was self-reported, or if it was charted based on the
provider’s perception of the patient. While this study is primarily focused on analyzing
the association between the patient’s charted race/ethnicity and the quality of medical
treatment provided, it is agnostic to the methods by which that perception is developed.
Finally, controlling for the patient’s insurance status in an attempt to control for
differences in the patient’s SES likely accounts for some but not all of the SES impact.
The results of this study imply that race/ethnicity, a socially constructed
categorization scheme rooted in relationships of power, continues to limit the quality of
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medical treatment for racial minority patients. For the first time, using a state-wide
database, incorporating PCRs from dozens of EMS agencies, and controlling for known
confounders, this study finds evidence that substantial racial/ethnic treatment disparities
are present when patients receive medical treatment from EMS providers. Specifically,
our results indicate that Hispanic and Asian patients were significantly less likely than
White patients to have their pain assessed by EMS providers and all racial / ethnic
minority categories were less likely to receive any pain medications for traumatic
injuries.
Given the consistency of these results with prior studies on medical treatment
disparities by race/ethnicity, and the nature of the mechanisms proposed to be
contributing to these disparities, there is little reason to suspect racial/ethnic treatment
disparities in EMS is limited to pain management. Future research should investigate
disparities in other EMS treatments, between-agency versus within-agency contributions
to these disparities, and with a better understanding of the potential mechanisms
involved, an evaluation of front-line training solutions designed to mitigate treatment
disparities.
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Chapter 3. Obesity and Treatment Disparities in EMS
This chapter has been accepted for publication as: Kennel, J., Woo, H., GarciaAlexander, G. Patients with LEP and EMS treatment. (Forthcoming, 2022). in GarciaAlexander, Ginny and Dudley L. Poston, Jr. (Eds.). International Handbook of the
Demography of Obesity. Switzerland AG: Springer Nature.
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Introduction
Many Americans are categorized as being overweight or having obesity, reaching

what several scholars consider epidemic levels (e.g., Rubenstein 2005). In fact, recent
body mass index (BMI; kilograms of weight divided by height in meters squared) data
from the Center of Disease Control and Prevention indicate that 79% of men and 77% of
women over the age of 20 in the U.S. are either overweight (BMI: 25-29), obese (BMI:
30-39), or severely obese (BMI: 40 and above) with even higher rates among Black and
Hispanic individuals (Fryar, Carroll, and Ogden 2016; Hales et al. 2018).
Not surprisingly, a large body of literature concerning obesity has focused on its
links to higher morbidity and mortality. For example, individuals with obesity are more
likely to suffer from many chronic health conditions including cardiovascular disease,
type 2 diabetes mellitus, respiratory disorders, various cancers, osteoporosis, and gall
bladder disease; and emerging evidence indicates they experience more serious COVID19 symptoms (Sanchis-Gomer et al. 2020; Visscher and Seidell 2001). Moreover,
individuals with obesity are more likely to have severe complications and consequences
from these conditions leading to increased risks of mortality (Busetto et al. 2020; Manson
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et al. 1995; Sanchis-Gomer et al. 2020; Visscher and Seidell 2001). Finally, mounting
evidence suggests that individuals with obesity are significantly associated with a higher
risk for “all-cause” mortality, compared to individuals without obesity (Di Angelantonio
et al. 2016; Calle et al. 1999).
In addition to these adverse health concerns, individuals with obesity also face
higher risks of negative social outcomes. People with obesity often encounter
discrimination at school and work. Studies indicate higher rates of school bullying and
school dropout rates, lower rates of employment, low income, and slower career
progression (Canning and Mayer 1966; Crandall 1991; Rubino et al. 2020). These
disturbing influences of obesity are also found in medical settings that individuals with
obesity are more likely to experience weight-related bias and receive substandard care
when utilizing healthcare services. For example, some research indicates that even
physicians who treat individuals with obesity reveal reduced cancer screening
recommendations and reluctance to perform pelvic exams, compared to physicians who
haven’t specialized in obesity treatments (Schwartz et al. 2003). Similarly, studies of
patients show that time receiving physician-led health education during clinical visits
tends to be shorter for patients with obesity than for those without obesity (Lee and Pausé
2016; S. M. Phelan et al. 2014).
Patients with obesity are more likely to experience negative interactions with
medical providers that are commonly characterized by disrespect, condescension, and
poorer treatment. This may worsen the morbidity and mortality burden of obese patients,
as such interactions have been shown to increase rates of treatment non-compliance and
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avoidance of medical care (Amy et al. 2006; Bertakis and Azari 2005; Budd GM,
Mariotti M, Graff D 2009; Hebl, Xu, and Mason 2003; Lee and Pausé 2016; S. M. Phelan
et al. 2014). Additionally, examples of weight bias in healthcare settings have been
associated with substandard treatment (Amy et al. 2006; Bertakis and Azari 2005; Hebl et
al. 2003; Phelan et al. 2015). Despite the evidence that obesity bias is associated with
attitudes of healthcare providers as well as their treatment recommendations, the link
between obesity and treatment outcomes has only been examined in limited areas of
medicine. Although Emergency Medical Services (EMS) provides medical treatment for
an estimated 16 million sick and injured individuals annually, often with acute morbidity
and mortality consequences, the presence of obesity treatment bias in EMS has not been
examined in this context.
In this chapter, we examine the association between obesity and EMS treatments,
using data from patient care records. In the sections below, we first review the theoretical
perspectives that shed light on how weight-related bias may operate for individuals with
obesity. We also provide a review of research documenting weight-related bias in
healthcare settings among those with obesity, including subgroup variations by gender
and its manifestations in treatment differences. Then, we perform an analysis of treatment
bias in EMS, an understudied medical setting, despite its importance in healthcare. Based
on our results, we discuss implications of the findings and offer directions for future
research.

3-2

Theoretical Guidance
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Obesity is a highly stigmatized condition, and those with obesity are at higher
risks of experiencing a host of adversities, including stereotyping, othering, status loss,
and discrimination (Link and Phelan 2001). Public attitudes toward individuals with
obesity are especially negative and scholars have argued this is largely due to the
attribution of blame or personal responsibility for excess weight. In other words, obesity
is presumed to be under a person’s control (Dejong 1980). Those who have obesity are
considered less active, less disciplined, and lazy, and they are therefore held personally
responsible for their obese condition.
Weight bias pervades many aspects of social life and has increased in recent
decades (Puhl and Heuer 2009). In fact, estimates suggest that up to 42% of adults in the
United States experience weight-based discrimination (Rubino et al. 2020). In health
settings, weight bias appears to be similarly widespread. A study of women observed that
69% of patients with obesity experienced weight stigma from a doctor and this kind of
experience occurred repeatedly for 52% of those patients (Puhl and Brownell 2006). Yet,
it is unclear how common weight bias is in an emergency medicine context and whether
this translates into differential practices and outcomes.

3-3

Empirical Evidence
In the healthcare system, there is ample empirical evidence suggesting that

physicians, medical students, and allied health providers stereotype individuals with
obesity as “lacking self-discipline”, “dishonest”, “unintelligent”, and “noncompliant with
treatment” (Budd GM, Mariotti M, Graff D 2009; S. M. Phelan et al. 2014; Teachman
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and Brownell 2001). As an indication of the strength of obesity stigma, these negative
perceptions toward obese patients are found even among physicians who specialize in
providing treatment to obese patients (Schwartz et al. 2003).
In addition, providers often recommend substandard treatment for people with
obesity. For example, while it is understood that people with obesity are more at risk for
cervical and ovarian cancer, medical providers are less likely to perform the necessary
pelvic exams to screen for these life threatening conditions (Amy et al. 2006). Further,
people with obesity report spending less time with medical providers and receive less
health education during medical appointments when compared to people without obesity
(Bertakis and Azari 2005; Hebl et al. 2003; Phelan et al. 2015). Some studies show that
gender moderates the association between weight and bias or discrimination, with women
experiencing greater penalties. For example, women are more likely to encounter
negative attitudes and treatment differences when interacting with medical providers
(Anderson et al. 2001; Fikkan and Rothblum 2012; Schulte et al. 2007).
On the patient side, negative attitudes and poor treatment across a variety of
providers are commonly reported. In fact, one study indicates that patients expect to
encounter negative stereotypes and stigma in primary care (Brown et al. 2006); several
others document disrespectful or upsetting comments on the part of providers (Puhl and
Brownell 2006). These negative perceptions and interactions have important implications
as they tend to demotivate adherence to obesity interventions. They have also been linked
to avoidance of care and delayed use of preventive health screenings for colorectal,
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breast, cervical cancer, and pelvic exams (Amy et al. 2006; Lee and Pausé 2016; Puhl and
Heuer 2010).

Emergency Medical Services
Emergency Medical Services (EMS) provides medical treatment for an estimated
16 million sick and injured individuals annually, often with acute morbidity and mortality
consequences. It is not known if patients with obesity are more likely to utilize EMS
services than patients without obesity. However, there is good reason to believe that
patients with obesity may rely on EMS more frequently than those without obesity.
Obese individuals have higher health risks and thus, tend to rely more on healthcare
overall (Fuoco 2010). Further, patients with obesity are more likely to delay medical
treatments which may arguably result in increased utilization of EMS services as
untreated medical conditions escalate (Rubino et al. 2020).
This study explores evidence of treatment and outcome disparities for obese
patients when they interact with EMS medical providers. Similar to other medical
settings, EMS providers are unlikely to be immune to the negative attitudes towards
obese patients found in other areas of medicine as well as in society at large. Thus, it may
be that obesity stigma exists and thus, results in negative impact on the quality of EMS
treatment and patient outcomes. In fact, EMS providers may be even more susceptible to
obesity bias for two primary reasons. First, EMS providers are often evaluated on the
speed at which various tasks are performed (e.g., scene times, transport times, time to
perform procedures, etc.). Given the presence of time constraints that many EMS
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providers face, stereotypes could be more likely to be activated, which may lead to
treatment disparities (Burgess 2010). Second, if EMS providers, like other healthcare
providers, believe that patients with obesity are more likely to be non-compliant with
their treatment recommendations, especially when they deal with additional scene
extrication challenges, operating additional personnel (e.g., for lifting and moving
assistance) or specialized equipment (e.g., a bariatric ambulance). In particular, EMS
providers may feel that they are being requested to primarily provide transportation to the
hospital. This might be perceived as a waste of EMS time and resources and may further
illicit negative attitudes and behaviors from the EMS providers.
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Research Question and Hypothesis
This study investigates the associations between a patient’s obesity status and the

quality and outcomes of the EMS medical treatment provided for patients who engage
with EMS for painful emergencies. We look at pain-related treatments and outcomes
because EMS treatment and pain-related treatment protocols typically allow the provider
considerable treatment discretion . To measure these associations, we focus on three
1

distinct, yet sequenced, components of the EMS encounter. The first component is the
administration of a pain screening, a process utilized by emergency providers to assess
the presence and severity of pain using a 0-10 pain scale. The second component is the

1

Prior research has demonstrated that the treatment of pain has been shown to vary on the basis of patient
characteristics when clinical uncertainty and or levels of provider treatment discretion is high (Bloche
2001; Mort, Weissman, and Epstein 1994; Smedley et al. 2003).
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receipt of pain medication. Prior studies have documented racial/ethnic disparities in the
receipt of pain medication (Hewes et al. 2017; Kennel et al. 2019; Todd et al. 1999), and
based on these studies it is expected that having obesity, a stigmatized condition, will
reduce the likelihood of receiving pain medication. Third, we examine pain outcomes,
based on patient’s self-assessment of pain. We look at the difference between a patient’s
pain level at the beginning and at the conclusion of EMS treatment. It is expected that
obesity status will reduce the likelihood of pain screening, pain medication
administration, and effective pain reduction during EMS treatment. We test the following
specific hypotheses:

H-1

When patients receive treatment from EMS providers for traumatic and

atraumatic painful emergencies, patients with obesity are less likely to receive a pain
screening when compared to patients without obesity, and the association is even more
salient for women.

H-2

When patients receive treatment from EMS providers for traumatic and

atraumatic painful emergencies, patients with obesity are less likely to receive pain
medications when compared to patients without obesity, and the likelihood of receiving
pain medications is even lower for women.

H-3

When patients receive treatment from EMS providers for traumatic and

atraumatic painful emergencies, patients with obesity are less likely to have their pain
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levels reduced when compared to patients without obesity, and the association is stronger
for women.

3-5

Data, Measures, and Methods

3-5-1 Data
This study utilizes patient care record (PCR) data from 2015-2019 for patients
who received emergency treatment from EMS services in the City of Vancouver,
Washington. The City of Vancouver was selected for two primary reasons. First, the City
of Vancouver granted access to the complete and private PCR dataset for both the
Vancouver Fire Department and American Medical Response (ambulance transport
agency), including population-level data access as well as several additional variables not
available in public EMS datasets (i.e. NEMSIS: National Emergency Medical Services
Information System). Second, the City of Vancouver data structure allows PCR data from
multiple EMS agencies that provide concurrent care to a single patient to be consolidated
into a single set of treatments. The PCR represents the official EMS medical record,
which captures all assessments and treatments provided to the patient during the entire
EMS encounter. As is common in many EMS systems, EMS treatment within the City of
Vancouver is often, but not always, provided concurrently by paramedics employed by
two independent EMS organizations: the contracted ambulance provider, American
Medical Response (AMR), and the City of Vancouver Fire Department (VFD). In the
current study, PCR data from AMR and VFD were combined to create a new single
comprehensive PCR that includes all assessments and treatments provided to the patient
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from either agency. By selecting data from the years 2015 – 2019, we capture the most
recent years of PCR data available with a single electronic charting environment for each
PCR system.
All PCRs with a primary impression of either atraumatic pain or a traumatic
injury are included. The primary impression value represents the working diagnosis as
determined by the EMS team, and from which a treatment plan follows. When two
different primary impression values existed for the same patient encounter, we use the
value from AMR.

2

Several exclusion criteria are applied in order to restrict the analysis to patients
who were clinically equivalent and eligible for pain treatment. First, patients with a
clinical contraindication for receiving pain treatment are excluded, including patients
with altered mental status or patients reporting an allergy to pain medications. Patients
with an altered mental status (AMS) are identified either through a secondary impression
of AMS or as having a charted Glasgow Coma Scale (GCS) of < 14. Next, patients with
allergies to Ketorolac, Fentanyl, Ketamine, Morphine, or “pain medications” are
excluded. Finally, interfacility or scheduled ambulance transports are excluded in order to
focus this analysis on patient interactions resulting from 911-initiated calls. The final
analytic sample resulted in 18,000 PCRs, of which VFD contributed PCR data in 2,513
cases.

2

AMR provided treatment for the vast majority (98%) of requests for emergency care compared to VFD
(14%) in the sample. Additionally, the AMR primary impression value is communicated to the emergency
department upon patient drop off at the hospital and is more likely to direct the majority of patient
treatment compared to the VFD primary impression.
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3-5-2 Measures
Treatment outcomes were measured using three variables for this analysis: (1)
completion of a pain screening; (2) pain medication administration; and (3) pain
reduction. A pain screening procedure, if performed, is captured in the PCR as a value
between 0, no pain, to 10, the most severe pain score. For the second variable, we create a
dichotomous variable to indicate if any pain medications were administered (yes=1;
no=0). EMS treatment protocols for the City of Vancouver include the following pain
medications: ketorolac, fentanyl, ketamine, and nitrous oxide. While multiple pain
medications were available to crews to use, 97% of the time fentanyl was used when a
pain medication was administered which limited our ability to analyze differences in the
use of different pain medications. For this reason, only fentanyl administration was
examined in this analysis. Pain reduction is the final outcome variable of interest. Most
patients who received a pain screening received at least two pain scores (98% of
patients), allowing for two treatment outcome variables to be created. Next, a variable
was created indicating if a patient had a change in their pain score by comparing the
beginning pain score to the ending pain score. PCRs with a positive change in pain scores
were designated as a pain increase, negative values were designated as a pain decrease,
and no change in pain scores were assigned a no change in pain value.
Our independent variable in this study is obesity status of the patient. Determining
obesity status using medical chart data is conventionally calculated using the Body Mass
Index (BMI) formula (kg/m ), incorporating an individual’s height and weight data.
2
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However, PCR data consistently captures patient weight, but EMS crews do not chart
patient height data. To arrive at height data, we use average height data by race and
gender using a nationally representative sample from the National Health and Nutrition
Examination Surveys (Fryar et al. 2018). Once BMI values were calculated, we
categorized cases into not obese (BMI<30), obese (BMI 30-39), and severely obese (BMI
40 and above) groupings for analysis.
The control variables considered in this analysis include both sociodemographic
and clinical variables that may confound the relationship between the primary and
outcome variables of interest. The sociodemographic variables used as controls include
patient race, patient gender, patient age, and the patient’s insurance status. A single race
value was derived for each PCR after evaluating the charted race values from both the
AMR and VFD PCRs resulting in the following race categories: White, Black, Asian,
Hispanic, Other, Unknown, and “Discordant”. The “Other” race category includes
“American Indian”, “Arab or Middle Eastern”, “Native Hawaiian”, “Pacific Islander”,
and “Other Race”. The “Discordant” race category included 23 PCRs (0.1% of the total
sample) where VFD and AMR charted race values that were in direct and specific
conflict (e.g., if, for a single call, one record indicated White and the other record
indicated Black). In cases where a specific race value (e.g., Asian or Black) was in
conflict with a race value of “other” or “unknown” the more specific race value was
maintained.
Patient gender is captured as a binary value (e.g., male, female) in both AMR and
VFD datasets. When a null value exists in one dataset and a non-null value in the other,
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the non-null value was used in the analysis. Where gender values are in direct conflict
between datasets, a new “discordant gender” value was created.
Patient age is captured as a continuous variable, expressed in years, in both
datasets. When a null value is provided in one dataset and a non-null value in the other,
the non-null value was used in the analysis. When both datasets had a patient age value
that is not in agreement and is less than 10 years apart, an average of the two values was
calculated and used in the analysis. When both datasets have a patient age value that is
not in agreement and is greater than 10 years apart, the open text narrative field in each
PCR was examined for indications of the correct age. Where the correct age could not be
confidently determined, a ‘discordant age’ value was imputed and treated as missing in
the analysis.
Additionally, this analysis uses the patient’s health insurance status as a proxy for
the patient’s socio-economic status (SES). Patient insurance information is captured in an
open text field in AMR PCRs that allowed for multiple entries. Each PCR was assigned a
single insurance status category based on the patient’s ‘highest’ level of insurance in the
following priority order: Private, Medicare, Medicaid, Other Government, No Insurance,
and Unknown insurance.
Several clinical variables were used as controls. First, all thirty unique
subcategory values within ‘traumatic’ and ‘atraumatic’ primary impression values were
utilized in the models for each outcome measure analyzed. Primary impressions represent
the EMS provider’s working diagnosis of the patient’s condition. Next, a dichotomous
variable was created to document if a pain assessment was performed (1) or not (0) for
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each case and was used on the models investigating pain medication, and pain reduction
outcome variables. Finally, since treatment is expected to vary by the patient’s pain level,
the patient’s first documented pain score (0-10) was incorporated as 11 distinct
dichotomous variables, one for each pain score value.

3-5-3 Methods
The sample population is characterized using bivariate descriptive statistics by
obesity status (Table 3-1 and 3-2). Next, two adjusted multivariable logistic regression
models were utilized to explore the relationships between the outcome variables (pain
screening, pain medication) and the predictor variables (obesity status) (Tables 3-3 and 34). Finally, an adjusted multinomial multivariable model was used to explore if obesity
status has a relationship on pain reduction (Table 3-5).

3-6

Results

Patient Characteristics
First, we present social/demographic characteristics of patients. As shown in
Table 3-1, the mean age of EMS patients is 61, and female, and white patients with nonprivate insurance who experienced traumatic injury are found to be more common users
of EMS, compared to male, and non-white patients with private insurance who had acute
pain, respectively. Additionally, the characteristics differ by obesity status. For example,
compared to patients without obesity, the mean age of patients with severe obesity in this
sample was younger (56 vs 62). Also, patients with severe obesity had higher proportions
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of female patients (68% vs 56%), Black patients (5.8% vs 2.4%), and Hispanic patients
(3.8% vs 3.0%), than those without obesity. Patients with severe obesity also had smaller
proportions of cases with Medicare or No Insurance, and higher proportions of patients
with Private or Medicaid health insurance when compared to patients without obesity.
Next, Table 3-2 shows unadjusted associations between obesity status and
treatment outcomes. As shown in Table 3-2, the proportion of patients who received a
pain screening is higher among those with obesity or severe obesity, compared to those
without obesity (72%, 75%, and 67%, respectively).
Additionally, a larger proportion of patients with obesity or severe obesity
reported being in severe pain (pain score of 7-10) when compared to non-obese patients
(57%, 63%, and 52%, respectively). Further, both obese and severely obese patients
received a higher average total dose of opioid pain medications (115 and 114 mcg
compared to 104 mcg). However, it is worth noting that while the average difference of
10-11mcg represents a statistically significant difference, it has minimal clinical
significance. Finally, in looking at changes from initial pain scores to pain scores after
EMS treatments, the majority of the sample (66%) reported no change in pain outcomes,
7% reported worsening pain, and 31% reported experiencing a reduction in pain, this
self-reported pain change does not appear to differ by the patient’s obesity status. In the
next section, we present results from logistic regression models.

Pain Screening Results
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For our first treatment outcome, pain screening, we present results of the
association of obesity status with pain screening in Table 3-3.
The results of Model 1, which adjusts for patient race, gender, age, health
insurance status, primary impression, and incident year, indicate that compared to
patients who are not obese, the odds of receiving a pain screening from EMS is higher for
patients with obesity (OR 1.24, p<.001), or severe obesity (OR 1.29, p<.001). Model 2
includes the interaction term between gender and obesity status using the same
adjustments as in Model 1, and the results show that while the odds of receiving a pain
screening is higher for patients with obesity compared to patients without obesity, the
“obesity advantage” appears attenuated for female patients (OR 0.76, p<.01). However,
this ‘female disadvantage’ was not observed among severely obese patients. Model 3
includes race and obesity interaction terms with the same controls adjusted in Model 1,
but the results show no evidence that the relationship between pain screening and obesity
status varies by patient race.

Pain Medication Results
Next, Table 3-4 shows the results of the logistic regression models examining the
relationship between obesity status and pain medication administration.
Similar to the models for the first outcome, Model 1 in Table 3-4 adjusts for
patient race, gender, age, health insurance status, primary impression, pain screening,
pain scores, and incident year. The results indicate that the odds of receiving pain
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medication are higher among patients with obesity (OR 1.11, p<.01)3. Model 2 presents
the results of our interaction analysis between gender and obesity status using the same
adjustments as in Model 1. The results show that there seems an advantage in receiving
pain medications for females (OR 1.16, p<.01). However, this advantage is eliminated for
females who are obese (OR 0.81, p<.05) and females who are severely obese (OR 0.67,
p<.01), although males with obesity or severe obesity still appear to receive a benefit or
increased likelihood of receiving pain medications. In Model 3, we add race and obesity
interaction terms to Model 1, and find no evidence that the relationship between pain
medication and obesity status varies by patient race.

Pain Outcome Results
Finally, we present results of two multinomial logistic regression models (Table
5) exploring the association obesity status has with the patient’s pain outcome (increased
pain, no change, or decreased pain).
Model 1 results indicates that after adjusting for patient race, gender, age, health
insurance status, primary impression, pain screening, pain scores, incident year, and if
pain medications were provided, patients with severe obesity are more likely to report an
increase in pain levels (OR 1.38, p<.01) after EMS treatment. Model 2 presents the

3

Model estimates were also run on sub-populations with mild (1-3), moderate (4-6), or severe pain (7-10)
scores with no significant findings
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interaction results of gender and obesity status using the same adjustments as in model 1,
and indicates that while females, overall, did not have evidence of an advantage or
disadvantage in this outcome compared to men, women with obesity were less likely to
report a reduction in pain (OR 0.75, p<.01) after their EMS encounter. Model 3 includes
race and obesity interaction terms and uses the same controls as model 1, and finds no
evidence that the relationship between changes in pain scores and obesity status varies by
patient race.

3-7

Discussion and Conclusion
The importance of the current analysis is mainly twofold. First, individuals with

obesity are likely to rely more heavily on EMS services as they are both more susceptible
to several diseases and often experience more severe consequences from disease. Yet, the
role of weight bias impacting treatment and outcomes in EMS is unknown. Second, by
addressing the treatment disparities associated with patient weight in EMS, this study
may provide implications for how treatment for patients with obesity can be improved in
when using EMS in the United States where weight related health concerns can be
applied to majority of adults.
In this study, our results indicate two important findings. First, compared to
patients who are not obese, those with obesity who engage EMS services for painful
conditions were more likely to receive a pain screening, report severe pain, and receive
pain medications. Second, having obesity or severe obesity negated the advantage that
female patients had in all outcome variables studied. We discuss our findings below.
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Pain Screening
Counter to our first hypothesis, which predicted reduced likelihood of pain
screening for patients with obesity, our results show that patients with obesity or severe
obesity were more likely to receive a pain screening compared to patients without
obesity. This finding was somewhat unexpected as it indicates an area of increased
treatment, rather than undertreatment, which has been observed in other medical settings.
When a pain screening was performed, patients with obesity and severe obesity were
more likely to be in severe pain compared to non-obese patients. Assuming there are not
significant differences in how patients with and without obesity experience pain, this is
potentially suggestive of delays in health-seeking behavior. Indeed, studies in other areas
of healthcare have found that patients with obesity are more likely to defer or skip their
healthcare appointments (Amy et al. 2006; Bertakis and Azari 2005; Lee and Pausé 2016;
J. C. Phelan et al. 2014). Although we are unable to test this directly, it is possible that
this same utilization pattern, i.e. avoidance or delayed care, is taking place in EMS.
Accordingly, patients with obesity may be more likely to engage EMS services for severe
or emergent pain; the signs and symptoms of which may be more suggestive of someone
in severe pain, encouraging EMS providers to complete a pain screening.

Pain Medications
Patients with obesity were more likely to receive pain medications, however
patients with severe obesity were not, when compared to patients without obesity. This
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finding is also somewhat counter to our second hypothesis that obesity status would have
a negative relationship with pain medication administration. These findings may be the
result of several influences and interactions. First, given the higher-than-average obesity
rate prevalent in the EMS workforce (80%) it is likely that an EMS provider with obesity
provided patient treatments. The increased rate of patient and provider obesity
concordance may provide a sense of solidarity and increased understanding that serves to
influence or overcome the negative effects of obesity bias for obese patients but not for
severely obese patients (Brice et al. 2019). While it’s been demonstrated that physicians
without obesity are more likely than physicians with obesity to more aggressively address
obesity related treatments, to our knowledge the association has not been studied in EMS,
and it is unclear if the painful conditions and corresponding treatment that instigated
EMS service in these cases would be perceived as treatments related to obesity (Wells et
al. 1984).
Further, when pain medications were provided, the amount of pain medication
administered was clinically equivalent across obesity status. Importantly, the primary
pain medication used by EMS providers in this sample of EMS interactions (fentanyl) has
a total available dose determination based on the patient’s weight (3mcg/Kg), allowing
for a larger dose for patients with obesity or severe obesity (Wittwer et al. 2018).
However, the analysis indicates that EMS providers did not take advantage of the larger
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dosing range available to them. While fentanyl is lipophilic4 its pharmacokinetic profile
is believed to be unaffected by increased adipose tissue, thus current hospital-based
recommendations suggest using a patient’s “ideal” body weight (versus actual body
weight or lean body weight) to determine proper dosing (De Baerdemaeker, Mortier, and
Struys 2004). EMS treatment protocols used by the City of Vancouver do not indicate
which patient weight to use, nor provide a recommendation on how best to determine
“ideal” body weight when calculating maximum total dosing (Wittwer et al. 2018). Since
a commonly understood side effect of administering excessive opioid pain medication is
respiratory depression, this result may indicate EMS providers may be unwilling to
provide additional opioid pain medications for obese and severely obese patients as
management of respiratory difficulties in obese and severely obese patients can be more
difficult and have poorer outcomes compared to non-obese patients (Mafort et al. 2016).
This represents an area of study that requires further investigation, both from the
standpoint of best practices in pain medication administration on the basis of weight and
implications for excess dosing in those with obesity.
Our findings further revealed gender discrepancies such that having obesity
diminished the likelihood of receipt of pain medication in females. Prior studies have
observed that women experience greater penalties related to weight bias in medical
settings. It is possible that this this is a manifestation of disparate treatment on the basis
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Lipophilicity is the affinity of a drug for a lipid environment and has become a critical parameter in

understanding how drugs are distributed, metabolized, and cleared once administered
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of gender. However, additional investigation is needed as it’s unclear why this hesitancy
may apply to obese women but not obese men.

Pain Outcomes
We predicted that improvements in pain levels, measured as the change in pain
screening scores at the beginning and end of EMS interactions, would be reduced in
patients with obesity. In other words, we expected less successful pain management
based on prior work suggesting undertreatment in this group. Our hypothesis was not
supported in patients with obesity, however it was supported in patients with severe
obesity as they were more likely to report an increase in their pain levels after receiving
treatment from EMS crews when compared to patients without obesity. Interestingly,
patients with obesity were more likely to receive a pain screening, be in more severe
pain, and were more likely to receive pain medications, yet did not show evidence of
having their pain reduced any more effectively when compared to patients without
obesity. It is possible that the increased dosages were insufficient to address the severe
pain found in patients with obesity (as described above). Similarly, patients with severe
obesity were also more likely to receive a pain screening, be in severe pain, however they
did not have evidence of an increased likelihood of receiving pain medication, and
logically were more likely to report increased pain levels after EMS interaction compared
to patients without obesity.

49

Gender and Obesity in EMS Treatment
For each outcome variable reviewed, women were more disadvantaged by having
obesity or severe obesity when compared to men. Regarding pain screening, women
without obesity, compared to men without obesity, were more likely to receive a pain
screening; however, having obesity eliminates this advantage for women while enhancing
it for men. Similarly, women without obesity are more likely to receive pain medication,
however having obesity or severe obesity eliminated this advantage for women while,
again, enhancing it for men. Finally, regarding pain outcomes, there was no evidence
indicating females overall experience different outcomes compared to men; however,
obesity once again had a negative impact on women but not men. These findings suggest
obesity bias has a gendered relationship which negatively affects only women across all
three outcomes in our study, consistent with other studies showing a penalty for women
with obesity, but not for men (Fikkan and Rothblum 2012).

3-8

Limitations and Suggestions for Future Research
This study has several limitations. First, because we sample PCRs from a single

metropolitan area (Vancouver, Washington), our results might not be generalizable to
EMS agencies in other locations, especially non-metropolitan areas, and thus applications
of our results require cautions. However, we believe that our findings provide an
important insight into the issue of potential treatment discrimination among patients with
obesity who engage with EMS, and urge the need for continuing regional and national
investigations. Second, despite consolidating PCRs from AMR and VFD into a single
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event PCR, the unit of analysis in this dataset remains chart-based, rather than patientbased. As mentioned earlier, it is possible that high-utilizer patients may be found more
among patients with obesity. Thus, we may have inadvertently included more overweight high-utilizer patients than normal weight high-utilizer patients. However, because
frequent utilization of EMS is not common, it is less likely that this data limitation is
present in our results in any significant ways. Third, it is unclear if the average height for
patients used to calculate obesity status in our sample matches the national average height
estimates. However, given the relatively large dataset used in this study, this limitation is
not believed to be substantial. Finally, as has been described elsewhere, BMI is a
relatively poor indicator for physical fitness. It is a crude measure simply based on height
and weight, not accounting for the amount of body muscle. Thus, men are more likely to
be counted as either overweight or obese when they have a more muscular build
(Roehling 2012). However, despite this measurement caveat, a consistent association
between BMI and health outcomes has been reported in the literature (Lee and Pausé
2016). Moreover, given that this potential overcount of muscular men as obese may
underestimate the influence of being obese on treatment outcomes, our findings here
should be considered as conservative estimates, serving as an important step toward
further disentangling the complex interactions between health providers and obese
patients.
These findings have several implications. First, they offer a critical advancement
in the study of weight-bias impacts on medical treatment in an understudied context of
medicine. Importantly, we observed that pain screenings were more likely for patients
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with obesity. This pattern of treatment suggests a few possibilities worthy of further
investigation. Future work should examine the extent to which obesity concordance
between patients and providers improves treatment outcomes. Additionally, avoidance
and delayed health-seeking behaviors among those with obesity may lead them to be
more likely to utilize EMS for care when symptoms become so severe they cannot be
ignored. If this is the case, EMS represents an important source of care for those with
obesity and additional investigation is needed to develop best practices in standards of
care. This would also seem to represent an ideal site for intervention and educational
strategies designed to reduce bias in health settings.
Second, as the first study that examined whether this translates into differential
practices in EMS, we observed that obesity increased the likelihood of both pain
screening and receipt of pain medication (though the amount was clinically minor) in the
EMS setting. This seems especially noteworthy given that time constraints have been
shown to increase stereotyping and worsen care. EMS interactions are arguably timecompressed, yet, our findings suggest that EMS providers may be more sensitive to or
aware of the needs of patients with obesity. More work is needed to determine the extent
to which this may be the case as well as the mechanisms underlying such an association.
Third, these findings also reinforce the importance of an intersectional analysis to
improve the understanding of the gendered nature of the effects of obesity stigma.
Women were disadvantaged in all outcomes. Though we are unable to directly test
whether bias is the underlying mechanism, it is a likely contributor given prior studies
suggesting greater penalties for women with obesity across various domains. We would
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like to invite further investigation to determine why females with obesity are
disadvantaged in this context.
Putting them together, we hope our results bring more awareness to the EMS
community regarding the role of obesity bias, especially for women, in influencing EMS
treatments. As rates of obesity continue to increase in the general population, particularly
in geographic areas with already high rates of obesity, such as the southeastern regions in
the United States, understanding and mitigating EMS obesity treatment disparities is
critical for EMS agencies. Additionally, while our study focused on pain management, it
is possible that obesity bias may negatively impact the treatments of other emergency
medical conditions. Finally, our results can be used to inform EMS agencies to create an
opportunity to better train and educate health providers in an effort to mitigate treatment
disparities.
Going forward, we suggest several areas of future research. First, work is needed
to better understand EMS utilization patterns and whether patients with obesity use EMS
more often, and if so under what conditions. Second, a more comprehensive
understanding of which health conditions, in addition to pain management, are
susceptible to substandard care among women with obesity is needed. Without awareness
and visibility to the nature of the problem, mitigation of the harmful effects will be less
effective. Finally, further exploration of how obesity bias impacts medical treatment
disparities for women across sociodemographic subgroups (e.g., race/ethnicity and age)
will be important to develop a more fulsome understanding of opportunities to reduce
disparities and increase the quality of care for patients.
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Obesity status is associated with improvements in some areas of EMS treatment
for men (i.e., pain screening, and pain medication administration). This unexpected
finding suggests that EMS may be a unique medical setting in which previously observed
patterns of undertreatment for those with obesity are not applicable. It is possible that this
is attributable to a pattern of delayed care and subsequently emergent/extreme pain
among those with obesity, which cannot be ignored. It is also possible that EMS
providers are less likely to engage in victim blaming or stereotyping than other medical
providers, perhaps due to an increased prevalence of individuals with obesity in the EMS
workforce. These interesting possibilities are worthy of continued investigation, and
subsequent work should attempt to confirm similar patterns in other outcomes and
directly examine EMS provider attitudes surrounding obesity. If EMS providers are
engaging in practices that improve outcomes for those with obesity, it is necessary to
determine why and how this occurs. We would also like to note that there is a consistent
negative impact on women compared to men across all studied outcomes. As the role of
bias may well be impactful among socially disadvantaged groups in EMS, efforts should
be made to ensure the highest standard of care for all the patients, including stigmatized
and marginalized ones.
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Chapter 4. Limited English Proficiency and Treatment Disparities in EMS

4-1

Introduction
The number of people in the United States with Limited English Proficiency

(LEP) is currently estimated to be 25 million, or 8.5% of the total US population; a figure
that has increased 80% since 1990 (Zong and Batalova 2015). The US Census Bureau
defines individuals with LEP as anyone over the age of five that reports speaking English
less than ‘very well.’ As expected, most LEP individuals are first generation immigrants
(81%), and in fact, it is estimated that about half of first generation immigrants have LEP
(Zong and Batalova 2015). In particular, LEP individuals are more common among
Latinx immigrants (63%) and Asian immigrants (21%), rather than immigrants of other
racial/ethnic groups. Additionally, LEP individuals tend to have lower levels of education
(46% without a high school education), and are twice as likely to live in poverty when
compared to those without LEP (Zong and Batalova 2015). Not surprisingly, these
overlapping and under-resourced identities that individuals with LEP experience in the
US are likely to make them particularly vulnerable to impairments to their health and
healthcare experiences.
Health disadvantages for individuals with LEP have been documented in many
studies for a wide range of health outcomes. For example, compared to those without
LEP, individuals with LEP tend to report lower levels of self-reported health (KirkmanLiff and Mondragon 1991), experience poor emotional and mental health at higher rates
(Ponce, Hays, and Cunningham 2006), experience higher levels of psychological distress
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(Kang et al. 2010), and are more likely to suffer from unmedicated hypertension (Kim et
al. 2017). Moreover, recent research indicates individuals with LEP are more likely to be
infected and suffer fatalities from SARS-CoV-2, the virus that causes Covid-19
(Karmakar, Lantz, and Tipirneni 2021).
Further exacerbating these negative health consequences, individuals with LEP
tend to face limited access to healthcare services. For example, compared to individuals
without LEP, those with LEP are twice as likely to be uninsured and lack a primary care
physician (Dubard and Gizlice 2008). Even when individuals with LEP obtain private
insurance, they are less likely to visit their doctor and more commonly do not complete
recommended medical care than patients fluent in English (Derose and Baker 2000; Shi,
Lebrun, and Tsai 2009). Moreover, when individuals with LEP do visit their physician,
they are more likely to suffer from unintended medication complications (Gandhi et al.
2000), and are more likely to leave the hospital or clinic against medical advice (Marcos
et al. 1973).
Currently, close to half of all hospitals (43%) in the United States provide
treatment for LEP patients on a daily basis. However, patients with LEP are still more
likely to receive a lower quality of healthcare compared to non-LEP patients (Kang et al.
2010; Ratna 2019). While sparse, existing research shows that individuals with LEP are
less likely, when compared to individuals without LEP, to receive breast, cervical, and
colorectal cancer screenings despite equivalent clinical indications (Eamranond et al.
2011; Jacobs et al. 2005) and are less likely to receive mammograms or pap smears when
clinically warranted (Marks et al. 1987; Woloshin et al. 1997). Further, patients without
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language concordance with their medical providers reported receiving less education
about their newly diagnosed medical condition, report poor interpersonal interactions
with the medical team, and lower satisfaction ratings with their most recent medical visit
then did patients with language concordance (Ngo-Metzger et al. 2007). These are just
some of the access and quality disadvantages that individuals with LEP face when
engaging healthcare services.
While treatment disparities for LEP patients have been empirically studied in
many different types of hospital based medical settings, the impact that LEP has on the
quality of medical care provided by EMS is largely unexplored (further discussed below).
The purpose of this study is to evaluate if patients with LEP receive a lower quality of
care when they engage Emergency Medical Services (EMS) for medical treatment.
Additionally, this study will explore if the use of a language interpreter influences the
quality of care for patients with LEP.

4-2

Theoretical Guidance
Although there is no sociological theory that directly provides explanations for

how LEP influences a patient’s treatment in EMS, several theoretical perspectives
including Social Worth Theory, Aversive Racism Theory, and Stigma Theory offer
useful applications for understanding how LEP may shape treatment disparities for LEP
individuals.
For example, individuals with LEP may experience challenges at several of the
“worth-establishment steps” described by Social Worth Theory (SWT). First, the theory
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proposes that a patient’s personhood is one of the first identifiers that care providers
ascertain before personal characteristics can be attributed or assigned to a patient. When a
patient is unable to communicate in the same language as their medical provider it
presents a clear barrier to the individual’s identification as a recognized member of the
community and thus may increase the odds that the patient will be perceived
anonymously (i.e., as a Jon/Jane Doe). Second, even if personhood status is achieved, all
three of the cultural characteristic categories suggested by SWT (social, interaction, and
legitimacy) are made less accessible by language discordance as the medical provider
attempts to gather pertinent details that may help elevate the patient’s perceived social
standing. Social characteristics, such as the patient’s occupation, class status, and
familiarity, all become more difficult to uncover when compared to English speaking
patients. In addition, without language concordance, interaction details become more
difficult for the medical provider to determine the patient’s deference to medical advice
and may make it easier for the provider to call into question the patient’s honesty and
thus motives for seeking treatment. And finally, patients with LEP may strain the medical
providers’ ability to accurately judge if the patient has selected the ‘correct’ medical
specialty for their given complaint or medical condition. In these ways, SWT theory
provides a conceptual framework wherein language discordance burdens the creation and
fulfillment of a patient’s value and legitimacy (called “social loss story” in SWT) through
communication difficulty. However, LEP status represents more than just a simple
communication barrier, it also represents various demographic and sociological attributes
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that also influence medical interactions, including race/ethnicity status, immigration
status, acculturation status, and a lack of familiarity of the US medical system.
Aversive Racism Theory (ART) can be used to help explain how these
demographic and sociologic characteristics that LEP status represents are likely to
influence medical treatments. As previously summarized, ART suggests that because of
an internal conflict taking place between an individual’s conscious and unconscious
beliefs, as well as the desire to minimize being seen as prejudiced, individuals are more
likely to express bias or discrimination in situations where internal and external conflict
are minimized. Whaley (1998) describes four specific characteristics in which
discriminatory behaviors are most likely to manifest which are useful in understanding
how LEP status may shape treatment disparities in medical settings. First, during a
medical encounter a patient is almost immediately, possibly without provider awareness,
categorized using the patient’s outwardly apparent social and demographic characteristics
and placed into an in-group or out-group status. Given that most healthcare organizations,
including EMS organizations, disproportionally employ white, English fluent, middleand upper-class individuals, patients with LEP who most likely racial or ethnic
minorities, poor, and not fluent in English are more likely to be categorized as out-group
members. Next, a language barrier will also diminish the ease with which medical
providers will be able to quickly learn about the patient’s individual details (i.e. their
family status, occupation, education level), thus they will be more likely to rely on
stereotypes which are known to be laden with bias. Third, patients without language
concordance with their medical provider are at a disadvantage in relaying their intent or
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desire for seeking medical treatment, leaving the medical provider to rely on their clinical
impression only. Empirical studies have shown that a patient’s perceived motivation for
seeking medical care can influence the treatment they receive, especially if the patient is
perceived to be dishonest in seeking pain medications. Finally, ART suggests that
medical providers do not wish to be seen as biased or discriminatory, so the presence of a
language interpreter during medical treatment of LEP patients may not only facilitate
patient and provider communication, but also establish social norms of equitable
treatment and remove contributing factors that facilitate discrimination. Accordingly, in
the cases where patients with LEP have an interpreter present, ART suggests we should
see a reduction in treatment disparity.
Similarly to ART, Stigma Theory (ST) is useful in further understanding the
influence LEP status has on medical treatment beyond the communication challenges it
presents. An individual’s level of English proficiency, among other attributes such as
race/ethnicity, religion, and dress, is often used as indicators of acculturation into the host
culture. Importantly, English proficiency, or lack thereof, may also be perceived as an
indicator of an individual’s desire or intent to acculturate, or not acculturate, into the
dominant host culture (Padilla and Perez 2003). This stigma, and the resulting bias and
discrimination, has been shown to be especially impactful when the personal attribute is
perceived to be a willful choice or the intent of the individual versus an inherent or
involuntary characteristic (Dejong 1980). In this way ST helps explain that individuals
with LEP may be perceived to be not fluent in English due to a willful desire to not
integrate or accommodate into the dominate culture which may legitimize any resulting
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discrimination on the part of the medical provider as a logical or justified consequence
(i.e., ‘you’re not trying, so why should I’).
Taken together, these theories reinforce the way in which the narrow view of an
‘exemplar’ member of society (who is known, has selected the correct medical service for
their condition, has pure medical treatment motives, and is either in the in-group or
desires to be) is constructed and provides the framework to show if, and in what medical
circumstances, deviations from this identity can engender discriminatory medical
treatments. Further, using these three distinct but overlapping theories provides a robust,
complex, and nuanced explanation of how medical care can be shaped for patients with
LEP through an improved understanding of (1) how communication challenges discredit
patients with LEP who receive EMS treatment (SWT), and (2) how interpersonal and
psychological mechanisms compromise patients with LEP when receiving EMS
treatment (ART and ST).

4-3

Empirical Evidence
As mentioned earlier, several studies have found evidence indicating patients with

LEP receive a lower quality of medical care including a reduced rate of preventative
medical screening recommendations, reduced provider education time during clinical
visits, poor interpersonal interactions with medical staff, as well as decreased satisfaction
levels with healthcare visits when compared to similar patients whom are fluent in
English (Eamranond et al. 2011; Jacobs et al. 2005; Kang et al. 2010; Marks et al. 1987;
Ngo-Metzger et al. 2007; Ratna 2019; Woloshin et al. 1997). While, to my knowledge,
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SWT, AR, or ST have not been empirically tested in an attempt to better understand how
a patient’s level of English fluency may influence the quality of their treatment, several
studies have examined how disadvantages experienced among patients with LEP could
be reduced.
In an attempt to address patient language barriers directly, many healthcare
systems incorporate language interpreters into their practice when providing medical
treatment for LEP patients. However, the results of interpreter use on patient outcomes
are not consistent. For example, in some studies, the use of qualified medical interpreters
in medical settings appears to increase the quality of communications during clinical
visits, healthcare utilization rates, clinical outcomes, and patient satisfaction (Flores
2005; Karliner et al. 2007). Further, these healthcare quality measures are likely to have
equivalent ratings when using a qualified interpreter as compared to receiving care from a
healthcare provider with language concordance (Green et al. 2005).
However, introducing a language interpreter into clinical visits can also introduce
new problems and challenges. In video reviews of patient and provider clinical
communications, communication errors, such as paternalistic editing, interpreter
omission, incorrect translations, and not providing explanation of a US based cultural
idiom were common when a language interpreter was used, and concerningly, most of the
errors (63%) were clinically significant (Flores 2005). Another study found no supporting
evidence for an improvement in patient satisfaction or in the quality of interpersonal
communications during clinical visits when LEP patients were provided with language
interpreters (Ngo-Metzger et al. 2007). Despite these inconsistent results, the previous
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studies suggest that the use of interpreters provides an overall improvement in the
healthcare experience for LEP patients when compared to language discordant situations
(Flores et al. 2012).
While evidence supports the importance of using qualified language interpreters
to improve LEP patient outcomes, many physicians still rely on untrained family
members, or often choose to ‘get by’ without using an interpreter despite their availability
(Diamond et al. 2009; Napoles et al. 2015; Ramirez, Engel, and Tang 2008). Similarly, in
Emergency Medical Services (EMS) language interpreters are not well utilized for LEP
patients (Tate et al. 2016).
As mentioned earlier, individuals with LEP are most likely to be Latinx or Asian
immigrants rather than immigrants from other racial groups. Given the differences in US
immigration selection patterns and experiences among immigrant among Latinx and
Asian immigrants (e.g., educational attainment, labor force participation), it is reasonable
to assume that the degree to which LEP is associated with treatment outcomes may also
vary by race, and thus exploring variations in the association between race and LEP
status may provide visibility to any racial variation in the relationship between LEP and
the outcome variables (Budiman 2020). In fact, prior studies demonstrate that mental
health treatment disparities by LEP status vary in severity by race and ethnicity (Sentell
and Braun 2012).

Emergency Medical Services
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The EMS system provides life-saving medical treatment to patients during
medical or traumatic emergencies outside of the hospital or clinic environment, providing
treatment to approximately 16 million patients annually (Medicine 2007). Individuals
with LEP receive treatment from EMS providers at a disproportionately higher rate
compared to proficient English speakers, however very little is known about the quality
of care they receive (Medicine, Literacy, and Health 2004; Tate 2015b). The few existing
studies on this subject indicate that individuals with LEP hesitate and often choose not to
request EMS services during medical emergencies due to anticipated communication
challenges, anticipated costs, lack of experience with EMS, and negative perceptions of
EMS services in their community (Ong et al. 2012; Subramaniam et al. 2010; Yip et al.
2014). With respect to treatment outcomes, one study provides three important findings
(Weiss et al. 2015). First, the demographics of individuals with LEP were different from
non-LEP individuals: LEP patients were more likely to be female and several years older.
Second, there was no difference in the amount of time the EMS team spent onscene or the time spent transporting the patient to the hospital. This is important because
some emergency conditions are extremely time sensitive (heart attacks, strokes, etc.) and
cannot be definitively treated outside a hospital. Third, individuals with LEP were more
likely to receive an electrocardiogram (ECG) assessment compared to non-LEP
individuals. However, two primary methodological limitations make this study’s findings
difficult to generalize to the broader EMS industry. First, in addition to the small sample
size noted by the authors (201 cases), it appears the comparison of interventions between
groups (LEP and non-LEP) was not made in relation to the patient’s clinical need (e.g.,
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did patients complaining of chest pain receive an ECG). Instead, the frequency with
which the intervention was performed for all patients (e.g., did patients complaining of all
conditions receive an ECG) was counted regardless of the patient’s complaint or medical
condition. Thus, their conclusion that there was no difference in the application of ECGs
between LEP and non-LEP patients is problematic. Additionally, sociodemographic
characteristics, including race/ethnicity, socioeconomic, and immigration status that are
known to be highly correlated to an individual’s LEP status (Zong and Batalova 2015)
were not included as confounding variables during analysis (Smedley et al. 2003). This
exclusion raises questions as to whether the study’s findings can be confidently attributed
to the patient’s LEP status or some of these other known confounding factors.

4-4

Research Questions and Hypothesis
The theoretical framework provided by SWT, ART and ST, discussed above,

provides guidance to test several potential relationships between LEP status and EMS
treatment. First, a patient’s inability to speak English is theorized by SWT to reduce the
medical team’s ability to efficiently and accurately learn about an individual’s personal
characteristics, thus disadvantaging the patient’s social worth determination, leading to an
increased likelihood of reduced treatment quality. Second, the theoretical framework
provided by ART suggests that in the medical setting of EMS, where rapid decisions are
made with incomplete information under time pressure, the hasty classification of
patients with LEP places them at a further disadvantage through the use of stereotypes,
outgroup membership assignment, and evaluating the patient’s treatment motivation
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without direct communication and make it likely that a reduced quality of care will result.
Third, ART predicts that the use of a language interpreter may serve as a defacto patient
advocate increasing social normative pressure for the EMS medical team to provide
equitable treatment.
Given this theoretical guidance, the present study investigates the association
between a patient’s LEP status and the quality of the EMS medical treatment received by
addressing the following research questions: (1) Do LEP patients receive a lower quality
of EMS treatment compared to non-LEP patients? (2) Does the presence of an interpreter
vary the treatment disparity for LEP patients? For these research questions, I examine
two treatment outcomes: pain screening and pain medication, and test the following
hypotheses.

Outcome 1 – Pain Screening Hypotheses

H1

Patients with LEP are less likely to receive a pain screening when receiving EMS

treatment for traumatic injuries when compared to patients without LEP.

H2

The likelihood of receiving a pain screening is greater for LEP-patients when an

interpreter was used, compared to LEP patients when an interpreter was not used.

Outcome 2 – Pain Medication Hypotheses
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H3

Patients with LEP are less likely to receive pain medication when receiving EMS

treatment for traumatic injuries when compared to patients without LEP.

H4

Patients with LEP without an interpreter are less likely to receive pain medication

when compared to patients with LEP and an interpreter.

4-5

Data, Measures, and Methods

4-5-1 Data
This study utilizes Patient Care Report (PCR) data from May 2015 – May 2021
for patients who received EMS services in Multnomah County, Oregon from American
Medical Response (AMR) – the sole contracted ambulance provider for this county. This
private dataset, provided by AMR, contained population-level data access as well as
several additional variables not available in public EMS datasets (e.g., NEMSIS: National
Emergency Medical Services Information System). A PCR, typically authored by the
primary EMS medical provider, represents the official medical record for the entire EMS
patient encounter, including all assessment findings, diagnoses, and treatment
interventions performed. The division of AMR that provides EMS services to Multnomah
County, which includes the Portland Metro area, provides medical services for
approximately 100,000 patients each year. The most recent six years of PCR data were
selected to provide sufficient statistical power to investigate potential treatment variations
for the presumably small proportion of LEP patients present in the dataset.
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All PCRs from adult patients (> 17 years of age) with a primary or secondary
impression of Traumatic Injury are included. The primary impression value represents the
working diagnosis as determined by the EMS team, and from which a treatment plan
follows. Patients with traumatic injuries were selected for two reasons; (1) they often are
eligible for pain management, which is one of the most common reasons patients request
EMS services, and (2) the pain management protocol provides significant treatment
discretion for the on-scene EMS provider.
Several exclusion criteria are applied to restrict the analysis to patients who are
clinically equivalent and eligible for pain treatment. Patients with a clinical
contraindication for receiving pain treatment are excluded, including altered mental
status, allergies to pain medications, respiratory depression, and/or hypotension. The final
analytic sample resulted in 58,848 PCRs (Table 4-1).

4-5-2 Measures
As mentioned above, treatment performance was measured using two variables
for this analysis: (1) completion of a pain screening; (2) pain medication administration.
A pain screening procedure, if performed, is captured in the PCR as a value between 0,
no pain, to 10, the most severe pain score. For pain medication administration, a
dichotomous variable is created to indicate if any pain medications were administered
(yes=1; no=0). EMS pain treatment protocols for Multnomah County include the
following pain medications options, all of which were included in the analysis:
acetaminophen, ibuprofen, ketorolac, fentanyl, sufentanil, morphine, and ketamine.
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The primary independent variable in this study is the patient’s LEP status
(dichotomously coded). At the time of this study AMR does not have a standardized
charting policy or practice indicating where or how to record if a patient has LEP or not.
As the majority of AMR’s electronic charting fields are restricted to selection of limited
answer values (“pull downs” or radio buttons), documentation of a patient’s LEP status is
effectively restricted to an open text narrative section of the chart. In reviewing of the
narrative section of each chart, I identified and characterized LEP patients through a twostep process: (1) searching for key words to identify charts for manual review (e.g.,
English, language barrier), and (2) a review of each chart identified in step 1 to verify
LEP status as well as to characterize the type of interpreter services used, if mentioned.
Based on the EMS provider’s narrative descriptions, interpreter utilization for each PCR
was characterized into one or more of the following categories: family or friends,
bystander, agency provided interpreter service (Language Line or fire department
interpreter service), EMS crew member as interpreter, informal technology tools (e.g.,
Google translate), interpreter used from an unknown source, and no interpreter used.
Interpreter categories were created after reviewing a sufficient number of PCR narratives
to reach saturation of the type of interpretation solution used during EMS treatment.
To validate the coding process outlined above, an independent EMS and public
health professional coded a 10% random sample of 6,000 narratives based on the same
coding criteria I developed. Although the second coder worked through a 10% of the
entire narratives mainly due to a large number of the narratives I utilized for this research
(i.e., a total of almost 60,000 narratives), I believe that a random sample of 6,000
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narratives would be sufficient to ensure an inter-coder reliability for the categorization of
LEP vs. non-LEP patients in this chapter. When compared the LEP narratives identified
by the independent coder with those by myself, the results demonstrated substantial
interrater agreement in both the identification of LEP status (kappa = 0.96), and
identification of interpreter status amongst LEP patients (kappa = 0.80).
The control variables considered in this analysis include both sociodemographic
and clinical variables that may confound the relationship between the independent and
dependent variables in this study. The sociodemographic variables used as controls
include patient race, patient gender, patient age, and the patient’s insurance status. A
single race/ethnicity value was recorded for each PCR in the following categories: White,
Black, Hispanic, Asian, Other, and Unknown. The “Other” race category includes Alaska
Native, American Indian, Arab or Middle Eastern, Native Hawaiian, Other Pacific
Islander, and Other Race. Patient gender is captured as a trinary value (female, male, and
unknown). Patient age is captured as a continuous variable expressed in years.
Additionally, this analysis uses the patient’s health insurance status as a proxy for the
patient’s socio-economic status (SES). Patient insurance information is captured in an
open text field in AMR PCRs that allowed for multiple entries. Each PCR was assigned a
single insurance status category based on the patient’s ‘highest’ level of insurance in the
following priority order: Private, Medicare, Medicaid, Other Government (VA, workers
comp), No Insurance, and Unknown Insurance.
Several clinical variables were used as controls. First, all 31 distinct traumatic
subcategory values were utilized in the models for each outcome measure analyzed. Next,
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a dichotomous variable was created to document if a pain assessment was performed (1)
or not (0) for each case and was used on the models investigating pain medication.
Finally, since treatment is expected to vary by the patient’s pain level, the patient’s first
documented pain score (0-10) was incorporated as 11 distinct dichotomous values, one
pair (0 or 1) for each pain score value.

4-5-3 Methods
The sample population is characterized using bivariate descriptive statistics by
both LEP status and interpreter status across demographic variables (Table 4-2) and
clinical variables (Table 4-3). Because of the sparse characterization of the LEP
population within EMS literature, additional descriptive analysis is performed to explore
the frequencies of interpreter solutions utilized in the field (Table 4-4). Next, several
adjusted multivariable logistic regression models were utilized to explore the
relationships between the outcome variables (pain screening and pain medication
administration) and the predictor variables (LEP status and interpreter status) (Tables 4-5
and 4-6). As LEP may be perceived differently by a patient’s race/ethnicity, interaction
terms between LEP status and race and ethnicity are explored in the regression models.

4-6

Results

Patient Characteristics
As shown in Table 4-1, patients with LEP represented 2% of the overall sample.
Patients with LEP were slightly older (mean of 58 vs 56), with a higher proportion that
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are female, non-white, and have Medicaid or no health insurance compared to patients
with LEP. While slightly less than half of the patients with LEP had an interpreter onscene (48%), those without an interpreter tended to be younger (55 vs 61), male (57% vs
43%) and without health insurance (58% vs 48%) when compared to LEP patients with
an interpreter.
Clinical characteristics of patients included in the study are shown in Table 4-2.
Overall, 62% of patients in the sample received a pain screening, however only 35% of
patients with LEP received a pain screening. Similarly, while 9% of all patients in the
sample received pain medication, only 7% of patients with LEP received pain
medication. However, when a pain screening was performed, there was no evidence to
suggest LEP status influenced pain medication administration (13% vs 11%, p<0.152).
Interestingly, a larger proportion of LEP patients, when compared to non-LEP patients,
received pain medication when a pain screening was not performed (5% vs 2%, p<0.001).
Regarding interpreter status, a larger proportion of LEP patients with an
interpreter received a pain screening (38%), compared to LEP patients that did not have
an interpreter (32%, p=0.019). Further, when a pain screening was performed there was
no evidence to suggest patients with LEP compared to patients without LEP, or LEP
patients without an interpreter compared to LEP patients with an interpreter, reported any
differences in pain severity scores.
As stated earlier, less than half of patients (48%) with LEP received any type of
language interpretation while receiving care for their traumatic injury from EMS
providers (Table 4-3). When interpreters were available for patients with LEP, most used
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family or friends (60%) or a bystander (20%) with a very small minority (6%) utilizing
the company provided interpreter solution.

Pain Screening Results
Four models were developed to examine the relationship between a patient’s LEP
and interpreter status and receiving a pain screening (Table 4-4). First, Model 1 estimates
the baseline relationship that LEP status has on pain screening while adjusting only for
patient race, finding that the odds of receiving a pain screening is 0.36 (p<.001) for
patients with LEP, which is 64% lower than that for English speaking patients. Next,
Model 2 incorporates additional adjustment for patient gender, age, health insurance
status, primary impression, incident year as well as patient race as incorporated into
Model 1, finding the odds of receiving a pain screening is 0.37 (p<.001) for LEP patients,
which is 63% lower than that for English speaking patients. Model 3 estimates the
baseline relationship that interpreter status has on pain screening while adjusting for
patient race, finding that the odds of receiving a pain screening for LEP patients with an
interpreter is 0.42 (p<.001), and for LEP patients without an interpreter is 0.31 (p<.001),
which is 58% and 69% lower (respectfully) than for English speaking patients. Finally,
Model 4 incorporates the same additional adjustments noted in Model 2, finding the odds
ratio of LEP patients with an interpreter to receive a pain screening is 0.44 (p<.001) and
for LEP patients without an interpreter is 0.31 (p<.001), which is 56% and 69% lower
(respectfully) than for English speaking patients. Additional models were run to analyze
(1) if the relationship between LEP status and pain screening varied by patient race and
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(2) if the relationship between interpreter status and pain screening varied by race.
However, the results are largely not significant, implying the relationship between LEP
status or interpreter status and pain screening does not vary by patient race/ethnicity
status (results available upon request).

Pain Medication Results
Next, I examined the relationship between LEP status and the administration of
pain medications for EMS trauma injury patients (Table 4-5). The results from Model 1
indicate that the odds of receiving pain medications is 0.77 (p<.05) which is 23% lower
than that for English speaking patients conditional on adjusting for patient race, gender,
age, insurance status, primary impression, and treatment year. The results from Model 2,
which also include the same adjustments from Model 1, indicate the odds of receiving
pain medications is 0.66 (p<.05) for LEP patients who do not have an interpreter, which
is 36% lower than that for English speaking patients. Model 3 adjusts for pain screening
in addition to the adjustments from Model 2, and found two noteworthy findings. First,
the odds of receiving pain medications is 5.52 (p<.001) for patients that receive a pain
screening, which is 550% higher than patients that do not receive a pain screening.
Second the results shown in Model 3 also indicate that Black and Other race/ethnic
patients are still less likely to receive pain medications when compared to White patients
despite a patient’s fluency in English. However, no disparity for Asian patients is
observed, suggesting that once pain screening is administered, Asian patients may not be
disadvantaged compared to White patients.
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4-7

Discussion and Conclusions
This research furthers our understanding of EMS treatment for patients with LEP

in three important ways. First, this study clearly illuminates the demographic
characteristics of the LEP patient population that requests EMS services. Second, by
analyzing a large sample of patient care records, this analysis also provides insight into
the various interpreter solutions used by EMS crews while treating LEP patients in the
pre-hospital setting. Finally, these results further our understanding of the ways in which
LEP status influences healthcare treatment disparities in EMS.

LEP Patient Characteristics
With over 1,100 LEP patient encounters identified, this analysis provides an
improved understanding of the demographic characteristics of patients with LEP who
engage EMS services in several ways. First, two percent of the population of patients
who engaged EMS services for traumatic injuries are patients with LEP. To my
knowledge, the relative size of the LEP population that EMS provides treatment for has
not been previously quantified. Given the lack of EMS charting standards in place to
consistently document patients with LEP, this estimate is likely conservative. Next, in
alignment with previous research, the current study found that patients with LEP were
more likely to be older and female when compared to patients without LEP (Weiss et al.
2015). Further, patients with LEP were also more likely to be racial minorities,
specifically, two times more likely to be Black, 44 times more likely to be Asian, and 49
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times more likely to be Hispanic, when compared to White patients. Additionally,
patients with LEP were three times more likely to have Medicaid, and four times more
likely to have Worker’s Compensation or no health insurance, when compared to patients
without LEP. This analysis reinforces and furthers the existing body of literature
indicating that LEP patients may be particularly vulnerable to both health and healthcare
disparities as they commonly occupy multiple overlapping discriminated characteristics
of race/ethnic minority status, low socioeconomic status, LEP status, and immigration
status.

Interpreter Use
Utilizing a qualified interpreter to facilitate communication between the patient
and the medical provider is critical to delivering quality care (Flores 2005).
Concerningly, despite having access to a qualified medical interpreter (e.g., cell phone,
Language Line access) only 5.5% of LEP patients received a qualified medical interpreter
and only 48% of all LEP patients received any type of interpreter support. In fact, it was
common for EMS crews to note in their PCR that the EMS team was unable to
communicate with the patient due to a language barrier, yet no steps were taken to
overcome the language barrier in the pre-hospital setting. It’s unclear if and how EMS
crew members on scene where able to sufficiently obtain a patient history, understand
details related to the traumatic injury, and obtain clear consent and collaboration with the
patient regarding their treatment plan without an ability to clearly communicate. To my
knowledge, this is the first time that interpreter utilization frequency has been quantified
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in EMS. Utilizing friends or family members on-scene to interpret was the most common
interpreter solution (60.3%), followed by the use of bystanders (20.2%), unknown
sources (9.1%), EMS crew members (3.9%), and informal technology tools (1.3%).

Pain Screening
The results of this analysis found support for the first hypothesis: patients with
LEP were less likely to receive a pain screening compared to patients without LEP.
Additionally, having any form of interpreter provided seemed to lessen the treatment
disadvantage experienced by LEP patients, providing support for hypothesis 2.2. When
patients with LEP did receive a pain screening, there was no evidence to suggest that
their pain severity was any different from patients without LEP. Similarly, there was no
difference in the distribution of pain severity scores between LEP patients with or
without an interpreter. These results suggest that while patients with LEP are at a
disadvantage in receiving a pain screening, they present in similar levels of pain to nonLEP patients.
These results also indicate that receiving interpreter services only minimally
improves the pain screening treatment deficiency experienced by patients with LEP.
There are at least two possible explanations for this. First, the PCR dataset allowed
analysis of the presence, but not sufficient data to evaluate the quality or efficacy of the
interpreter support, therefore, given the low rates of use of qualified medical interpreters,
the overall benefit of interpreter services may have been insufficient to fully overcome
the language barrier presented. Second, LEP patients represent a distinctly marginalized
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population with overlapping characteristics, each prone to discrimination and treatment
bias in medical settings (e.g., race/ethnicity, low socioeconomic status, LEP) that are
likely not overcome with the use of an interpreter.
Interestingly, a subset analysis (results not shown, but available upon request) did
find that Hispanic patients with LEP were more likely to receive a pain screening when
compared to English speaking Hispanic patients. While this result is surprising, it is
theoretically supported, in that the use of a language interpreter during EMS treatment
may increase the social pressure on the EMS provider to provide ‘correct’ treatment, thus
making it more difficult to provide discriminatory care. According to ART, the presence
of an interpreter may directly or indirectly be increasing the external (interpreter’s
presence advocating for a pain screening) influences in relation to the internal (potential
tendency toward biased care) influences the EMS provider experiences and thus making
the delivery of disparate care more difficult to deliver when compared to Hispanic
patients who are English speaking without an interpreter present. There was no evidence
to support this relationship taking place with other racial/ethnic minority groups, however
small populations of intersecting racial/ethnic categories and LEP status may have
precluded visibility to this relationship in other racial/ethnic minorities as Hispanic
patients had the largest proportion of LEP patients amongst the other racial/ethnic
minority groups.
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Pain Medication
Patients with LEP were less likely to receive pain medications when compared to
patients without LEP (hypothesis 2.1). The influence that LEP status has on pain
medication administration seems to be partially mediated by the likelihood of receiving a
pain screening. The positive association between receiving a pain screening and receiving
pain medication is well established in the literature and results from this study may
indicate that this relationship is of particular importance to patients with LEP (Chang et
al. 2014; Hewes et al. 2017). Further, there was no evidence to support LEP patients with
an interpreter received pain medications any differently than English speaking patients
implying that the use of an interpreter may be beneficial in reducing pain medication
administration disparities.
The results of this work also expand the understanding of how patient race may
influence medical treatment in several ways. First, counter to other studies which
concluded that LEP status fully explains racial access differences in several areas of
healthcare, this analysis provides evidence that the observed racial treatment disparities
persisted across all racial minority categories despite adjusting for English language
proficiency (Cheng, Chen, and Cunningham 2007; Sentell, Shumway, and Snowden
2007). Next, while Asian patients’ pain medication treatment disparity seems to be
mediated through the receipt of a pain screening, this does not take place for Black
patients. This finding may suggest that Asian patients, but not Black patients, are less
likely to receive pain medications due to interpreter support barriers via a reduction in the
chances of receiving a pain screening.
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4-8

Limitations and Suggestions for Future Research
This study has several limitations. First, because it uses a retrospective sample of

PCRs from a single EMS organization providing ambulance services in Portland, Oregon,
the results of this study may not be generalizable to other EMS agencies or other
locations. Therefore, the results of the study should be interpreted with caution. Second,
the unit of analysis in this dataset is encounter-based, not patient-based, which may overrepresent high-utilizer patients in the analysis. LEP EMS utilization rates are unknown in
this dataset, and moreover, it is not clearly known whether patients with LEP are more
likely to use EMS, compared to those without LEP. For these reasons, it is difficult to
know whether and how this data limitation may impact the results of the study. However,
the findings in this study should provide useful insights to efforts to mitigate treatment
disadvantages for patients who are not proficient in English. Third, the manual
identification process utilized to identify patients with LEP within the dataset may not
comprehensively identify all LEP patients as it relies on the EMS provider to chart the
patient as LEP in an open-text field. This limitation is likely to underestimate the
presence of LEP treatment disparities uncovered. Finally, data was unavailable to
determine the quality of the interpreter so the effectiveness of the interpretation solution
used could not be factored into the analysis.
The results of this study have several implications for future research, practice,
and policy. First, comprehensive demographic studies of the LEP population are needed
to help inform the EMS industry about the level of support that is needed to adequately
80

care for this large and growing population. Next, improved practice guidelines, policies,
and training efforts are needed to improve the medical charting of LEP patients within the
PCR. Next, with an overall interpreter utilization rate of less than 50%, and a qualified
medical interpreter use rate of 5.5%, further work is needed to explore the barriers to
effective language interpretation use in the EMS setting. Finally, research into the
efficacy of the various forms of language interpretation used is needed as there is
considerable deviation from common interpretation practices used in other time sensitive
medical environments such as in hospital-based Emergency Departments.
In summary, individuals with LEP who receive medical treatment from EMS
providers are more likely to be female, older, Asian or Hispanic, and economically poor
when compared to non-LEP patients. Individuals with LEP were less likely to receive a
pain screening when compared to non-LEP patients, however LEP status conferred an
advantage for Hispanic patients but not other racial/ethnic groups of patients. Patients
with LEP were less likely to receive pain medications compared to English speaking
patients. Less than half of patients who were noted by EMS providers to have LEP were
noted to receive a language interpreter despite all EMS providers having access to
qualified medical interpreters. When interpreters were used, they were most likely to be
informal, adhoc, untrained interpreters versus qualified medical interpreters and their
presence reduced but did not eliminate the pain screening disparity.
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Chapter 5. Conclusion

5-1

Summary of Findings
The research presented in the previous chapters has provided several new and

important findings. First, racial/ethnic minorities who receive treatment from EMS
clinicians after suffering traumatic injuries or for painful conditions were found to be
more likely to receive a lower quality of care when compared to White patients. Second,
having obesity was shown to negatively impact the quality of EMS treatment for women,
but conferred an advantage for men. Next, while patients with LEP received a reduced
quality of EMS treatment, LEP status seems to confer a benefit for the treatment of
Hispanic patients in pain screening.
Racial/Ethnic Treatment Disparities in EMS Summary
While adjusting for differences in patient age, gender, and primary impression
categories, Hispanic and Asian patients, but not Black patients, were found to receive a
pain screening less often than White patients when being treated by EMS for traumatic
and painful conditions. In addition, all racial minority categories studied were less likely
to receive pain medication when compared to White patients, even when adjusting for the
differences in health insurance status. These findings are both predicted by Social Worth
Theory and Aversive Racism Theory and are consistent with findings in other areas of
medicine.
There are several potential explanations that may account for these findings. First,
the distrust among racial and ethnic minority populations toward the medical system may
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also exist in EMS, resulting in a tendency among these patients to limit engagement with
EMS to transportation to the hospital for further treatment. If EMS providers are unable
to earn the trust of racial and ethnic minority patients during life-threatening conditions,
higher (yet avoidable) rates of reduced treatment and mortality among racial and ethnic
minority, than among their counterparts, are expected. Future studies are needed to
further explore rates of treatment refusal, rates of EMS provider treatment advocacy, and
any disparities in those rates between various populations. Second, the time-compressed
nature of EMS care likely increases the use of patient stereotypes, resulting in higher
chances of discriminatory care for racial and ethnic minority patients. The treatment
disparity burden from rapid treatment is likely to be reduced over time as evidence is
increasingly suggesting that a slower pace of EMS treatment is clinically warranted in all
but a few patient conditions. Finally, the likely high rate of racial/ethnic discordance
between EMS provider and patient may reduce the ability for the EMS provider to
recognize authentic expressions of pain from what might be misunderstood and
potentially interpreted as pain medication seeking behavior.
These results have several important implications. First, the results from this
research strongly imply that race/ethnicity, a socially constructed categorization scheme
rooted in relationships of power, continues to limit the quality of medical treatment for
racial minority patients. Further, these results suggest that EMS providers are just as
likely to provide disparate treatment based on race/ethnicity as providers in other areas of
medicine. The importance of these results is magnified by the role that EMS plays for
racial and ethnic minorities, as they are more likely than White patients to use the EMS
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system as their initial entry point into the healthcare system. This work adds to the robust
evidence of lower quality of care for racial and ethnic minorities, which suggests the need
for additional research to better understand and mitigate this treatment inequity.

Obesity Treatment Disparities in EMS Summary
One of the more surprising results from this research was that men received a
substantial treatment advantage from having obesity while women with obesity received
a disadvantage across each outcome measure studied including pain screening, pain
medications, and treatment outcome. Similar to other research findings regarding
evidence of healthcare avoidance, it appears that individuals with obesity may be
delaying or avoiding calling EMS for assistance until pain levels become unbearable as
they present with significantly higher pain scores, on average, than patients without
obesity. This potential evidence of avoidance, in addition to evidence of treatment
disparities for women with obesity, may indicate higher levels of distrust in the EMS
system due to bias from obesity stigma. Further, these results also suggest that patient and
provider concordance may have benefited obese male patients, and that an increase in
gender diversity in EMS may further reduce obesity related treatment disparities for
women.
The results from this research effort have several important implications. First,
despite the trend of escalating rates of obesity in the United States, the role that obesity
bias plays in EMS treatment and outcomes is unknown. The findings from this study help
to bring attention to the role that obesity bias can have in EMS treatments. The advantage
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that men with obesity experienced was not anticipated and may imply that EMS may be a
unique medical setting in which previously observed patterns of undertreatment for those
with obesity are not applicable. Next, female patients with obesity were disadvantaged in
all outcome measures which demonstrates the importance of an intersectional analysis
and provides additional evidence of the gendered effects of obesity stigma. As the
majority of the US population manages life, including healthcare interactions, with
obesity, understanding and mitigating the effects of obesity stigma on the quality of EMS
treatment for Women is critical.

LEP Treatment Disparities in EMS Summary
Individuals with LEP who receive medical treatment from EMS providers are
more likely to be female, older, Asian or Hispanic, and economically poor when
compared to non-LEP patients. Individuals with LEP were less likely to receive a pain
screening when compared to non-LEP patients, however LEP status conferred an
advantage for Hispanic patients. Patients with LEP were less likely to receive pain
medications compared to patients without LEP. Less than half of LEP patients being
treated by EMS providers received a language interpreter, despite all EMS providers
having access to an interpreter. When patients with LEP used interpreters, they were most
likely to be informal, adhoc, untrained interpreters versus qualified medical interpreters.
Patients with LEP that had an interpreter were more likely to receive a pain screening
when compared to LEP patients without an interpreter, and did not have any evidence of
pain medication administration disparities when compared to patients without LEP. This
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evidence of interpreter effectiveness in reducing treatment inequity is encouraging and
warrants further exploration into interpreter utilization barriers, interpreter selection, and
communication efficacy during various medical conditions.
While the theoretical guidance for this study was not directly tested, the empirical
results reinforced its utility in two ways. First, as theoretically suggested, overall, LEP
patients did receive an anticipated lower quality of medical treatment from EMS
providers when compared to English speaking patients. Second, the use of interpreters
had variable impact depending on the patient population subset and outcome measure.
For example, LEP patients that had an interpreter had an advantage on both outcome
measures, suggesting that interpreters may play a role in reducing the treatment
disparities for LEP patients. However, in the case of pain screening outcomes the use of
interpreters for LEP patients, while presumably improving communication, didn’t
eliminate the treatment disparity, which may suggest the communication benefit received
through the use of the interpreter may have been insufficient to overcome the lower social
worth estimation, increased levels of bias, and stigma that may accompany patients with
LEP.
While each study has its own unique set of limitations, further discussed in each
chapter, they also share many limitations including relying on the accuracy and
completeness of medical chart data and being limited to designated geographies, thus
generalizing the findings across the EMS industry should be done with caution.
Accounting for these limitations, this study reveals new insights into the social influences
of EMS treatment quality.
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5-2

Conclusions
The results from this research suggest three overarching conclusions. First,

racial/ethnic minorities, compared to White patients, are more likely to receive a lower
quality of care from EMS providers. Second, obesity negatively impacts the quality of
EMS treatment for women, but confers an advantage for men. Third, patients with LEP
received a reduced quality of EMS treatment overall when compared to English
proficient patients, and use of an interpreter mitigated some but not all of the treatment
disparity.

5-3

Implications and Future Research
Differences in the quality of healthcare services may start well before individuals

reach a hospital or clinic environment, and in the research presented here we see how
medical treatment disparities may be introduced by EMS providers in the pre-hospital
setting. Knowledge of this phenomenon provides an opportunity to intervene sooner in
the healthcare continuum of care. In addition, these results contribute to the larger body
of knowledge supporting the profound impact that a patient’s social characteristics can
have on their healthcare treatment. Next, these findings confirm that the EMS industry as
a whole, and EMS providers individually, are not immune to these influences, just as it
has been seen in other areas of healthcare. Finally, the theoretical guidance outlined by
SWT, AR, and Stigma theories provide an accurate framework through which to
understand the medical contexts in which treatment disparities are likely to manifest.
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EMS is arguably several decades behind other areas of medicine in gaining
visibility and understanding of treatment disparities. While concerning, this also provides
an opportunity to learn from the challenges experienced by other medical specialties and
more rapidly move from a place of documenting disparities to eliminating them. In order
to move in this direction several areas of future work are needed. First, many of the
underlying mechanisms have been theorized (e.g., social worth, biological concept of
race, cognitive load theory, aversive racism) but their direct applicability and
operationalization to the unique EMS industry environment needs further specification.
Next, with an improved understanding of the mechanisms involved, additional research is
needed to target mitigating interventions, with specific focus on strategies that have
shown progress in other areas of medicine including efforts designed to improve provider
awareness of their own potentially disparate behaviors, reduce the level of treatment
discretion available to providers where patient conditions lack objective clinical
indications, and increase support and oversight for treating LEP patients. Finally,
recognizing the largely free market economy in which healthcare and EMS operates,
further regulatory policy research and change is needed to contractually incentivize EMS
agencies to transparently report on and mitigate treatment disparities by social
characteristics such as race/ethnicity, gender, body size, and language status, among
others.
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Tables
Table 2-1: Summary Statistics by Race
Table 2-1: Summary Statistics by Race (n,%)
Total
(n=25,732)

White
(n=22,105)

Black
(n=1,418)

Hispanic
(n=1,290)

Asian
(n=514)

Other
(n=405)

59, 23
13,094 (50.9)

61, 23
11,562 (52.3)

44, 19
570 (40.2)

41, 18
489 (37.9)

59, 23
299 (58.2)

48, 21
174 (43.0)

6,943 (27.0)
2,800 (10.9)
7,624 (29.6)
863 (3.4)
7,502 (29.2)

6,252 (28.3)
2,104 (9.5)
7,093 (32.1)
755 (3.4)
5,901 (26.7)

199 (14.0)
353 (24.9)
208 (14.7)
26 (1.8)
632 (44.6)

283 (21.9)
191 (14.8)
123 (9.5)
52 (4.0)
641 (49.7)

103 (20.0)
59 (11.5)
127 (24.7)
6 (1.2)
219 (42.6)

106 (26.2)
93 (23.0)
73 (18.0)
24 (5.9)
109 (26.9)

16,866 (65.5)
5,697 (22.1)
723 (2.8)
2,446 (9.5)

14,306 (64.7)
5,251 (23.8)
627 (2.8)
1,921 (8.7)

1,133 (79.9)
47 (3.3)
3 (0.2)
236 (16.6)

823 (63.8)
233 (18.1)
73 (5.7)
161 (12.5)

404 (78.6)
22 (4.3)
7 (1.4)
81 (15.8)

200 (49.4)
144 (35.6)
13 (3.2)
48 (11.9)

Clinical Characteristics
Pain Assessment

11,332 (44.0)

9,847 (44.5)

640 (45.1)

497 (38.5)

182 (35.4)

166 (41.0)

Pain Score (mean, SD) a
None (score = 0)
Mild (score = 1-3)
Moderate (score = 4-6)
Severe (score = 7-10)
Received Pain Medications

4.3, 3.1
1,981 (17.5)
2,380 (25.0)
3,404 (30.0)
3,117 (27.5)
5,000 (19.4)

4.2, 3.1
1,810 (18.4)
2,555 (25.9)
2,935 (29.8)
2,547 (25.9)
4,450 (20.1)

5.8, 3.0
57 (8.9)
101 (15.8)
185 (28.9)
297 (46.4)
197 (13.9)

5.1, 3.0
52 (10.5)
101 (20.3)
167 (33.6)
177 (35.6)
222 (17.2)

4.0, 2.9
39 (21.4)
39 (21.4)
67 (36.8)
37 (20.3)
73 (14.2)

4.9, 3.1
23 (13.9)
34 (20.5)
50 (30.1)
59 (35.5)
58 (14.3)

Patient Characteristics
Age, y (mean, SD)
Female
Health Insurance
Private
Medicaid
Medicare
Other and Government
Uninsured
EMS Encounter Geography
Urban
Rural
Frontier
Unclassified

a

1st recorded pain score
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Table 2-2: Summary Statistics by Traumatic Injury Categories and Race
Table 2-2: Summary Statistics by Traumatic Injury Categories and Race
Received a Pain Assessment
Total
White Minority
a

%

%

%

33.3
28.3
50.0
100.0
26.9
6.7
19.7
0.0
23.3
27.5
44.1

0.913
0.514
0.101
0.197
0.011
0.023
0.062
–
0.566
0.735
0.001

23.9
37.4
13.3
10.0
6.5
44.2
35.1
40.0
12.1
33.1
19.1

24.0
38.9
15.4
11.1
6.6
44.8
36.1
41.8
13.4
35.1
19.8

23.8
28.3
0.0
0.0
6.3
36.7
27.3
25.0
6.7
20.3
15.3

0.986
0.167
0.551
0.725
0.883
0.388
0.157
0.261
0.309
0.015
0.000

40.9

0.000

19.4

20.1

15.2

0.000

Primary Impression

n

%

%

%

Abdomen
Back
Chest (non-cardiac)
Genitals
Head
Hip / Pelvis
Lower Extremity
Multiple Injuries
Neck
Upper Extremity
Other / Unspecified

71
342
15
10
2,163
423
615
110
149
499
21,335

32.4
32.5
13.3
40.0
33.1
23.6
29.6
0.0
27.5
29.3
46.9

32.0
33.1
7.7
33.3
34.2
24.9
30.8
0.0
28.6
29.5
47.4

25,732

44.0

44.5

Total
a = Pearson Chi-Square
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Received Pain Medication
Total
White Minority

p

a

p

Table 2-3: Multivariable Logistic Regression of Patient Race on Pain Assessment
Table 2-3: Multivariable Logistic Regression of Patient Race on Pain Assessment
Adjusted a

Unadjusted
Regressor
White (referent)
Black
Hispanic
Asian
Other Race
Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

B

0.24
-0.25
-0.38
-0.15

OR

1.02
0.78***
0.68***
0.87

CI 95%

(0.92 - 1.14)
(0.70 - 0.88)
(0.57 - 0.82)
(0.71 - 1.06)

B

0.00
-0.23
-0.37
-0.26

OR

CI 95%

1.00
0.79***
0.69***
0.77*

(0.89 - 1.12)
(0.70 - 0.90)
(0.57 - 0.84)
(0.62 - 0.96)

-0.24
25,732
35,269
0.002

-0.24
25,732
32,040
0.160

Note: B = logistic regression coefficient and OR=odds ratio
* p<.05, **p<.01, *** p< .001
a
= Adjustments include: patient gender, patient age, patient age squared, patient health insurance,
geographic location, and EMS provider's granular primary impressions (dichotomous).
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Table 2-4: Multivariable Logistic Regression of Patient Race on Pain Medication
Administration

Table 2-4: Multivariable Logistic Regression of Patient Race on Pain Medication Administration
Adjusted a

Unadjusted
Regressor
White (referent)
Black
Hispanic
Asian
Other Race
Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

B

-0.45
-0.19
-0.42
-0.41

OR

CI 95%

0.64***
0.83*
0.66**
0.66**

(0.55 - 0.75)
(0.71 - 0.96)
(0.51 - 0.84)
(0.50 - 0.88)

-1.422
25,732
25,283
0.004

B

-0.39
-0.23
-0.27
-0.53

OR

CI 95%

0.68***
0.79**
0.76*
0.59***

(0.58 - 0.79)
(0.68 - 0.93)
(0.59 - 0.99)
(0.44 - 0.78)

-1.422
25,732
23,738
0.096

Note: B = logistic regression coefficient and OR=odds ratio
* p<.05, **p<.01, *** p< .001
a
= Adjustments include: patient gender, patient age, patient age squared, geographic location,
pain assessment (dichotomous), pain assessment initial score, pain assessment initial score squared, patient health
insurance, and EMS provider's granular primary impressions (dichotomous).

92

Table 3-1: Demographic Characteristics of PCR Data by Patient Weight
Table 3-1: Demographic Characteristics of PCR Data by Patient Weight
Total
n

Total
Age, y (mean, SD)
Gender
Male
Female
Race
White
Black
Asian
Hispanic
Other
Unknown
Insurance
Private
Medicare
Medicaid
Other Gov't
No Insurance
Unknown
Primary Impressions
Traumatic Injury
Abdominal Pain
Back or Body Pain
Pain Management

18,000
61 (22)

Not Obese
(BMI < 30)

Obese
(BMI 30-39)

%

%

n

67% 11,987
62 (24)

n

Severely Obese
(BMI > 39)
%

n

sig

23% 4,220
58 (20)

10% 1,793
56 (17)

0.000

43.2% 7,769
56.8% 10,231

43.6% 5,223
56.4% 6,764

46.6% 1,965
53.4% 2,255

32.4% 581
67.6% 1,212

0.000
0.000

81.4%
2.9%
1.3%
3.4%
10.4%
0.6%

14,656
519
226
609
1,875
115

83.0%
2.4%
1.6%
3.0%
9.5%
0.6%

9,944
282
191
358
1,142
70

78.2%
3.2%
0.6%
4.3%
13.0%
0.7%

3,300
133
26
182
550
29

78.8%
5.8%
0.5%
3.8%
10.2%
0.9%

1,412
104
9
69
183
16

0.000
0.000
0.000
0.000
0.000
0.157

19.3%
26.1%
13.2%
1.8%
20.9%
18.7%

3,475
4,703
2,374
330
3,753
3,365

18.4%
27.5%
11.9%
1.8%
21.4%
19.0%

2,206
3,292
1,425
211
2,570
2,283

21.6%
23.2%
14.1%
2.2%
20.5%
18.4%

910
978
595
94
867
776

20.0%
24.1%
19.7%
1.4%
17.6%
17.1%

359
433
354
25
316
306

0.000
0.000
0.000
0.052
0.001
0.113

59.3%
18.4%
18.2%
4.1%

10,680
3,311
3,277
732

61.7%
17.8%
16.5%
4.1%

7,391
2,132
1,975
489

56.7%
17.8%
21.1%
4.4%

2,392
753
890
185

50.0%
23.8%
23.0%
3.2%

897
426
412
58

0.000
0.000
0.000
0.118
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Table 3-2: Clinical Characteristics of PCR Date by Patient Weight
Table 3-2: Clinical Characteristics of PCR Data by Patient Weight
Not Obese
(BMI < 30)

Total
n

Obese
(BMI 30-39)

%

n

%

11,987
3,910
8,077
856
1,141
1,892
4,188

23%
27.7%
72.3%
6.7%
12.8%
23.4%
57.2%

n

%

67%
32.6%
67.4%
10.6%
14.1%
23.4%
51.9%

Pain Medication Admin Rate Overall (n=18,000)
patients without pain screening (n=5,528)
patients with pain screening (n=12,472)

19.1% 3,434
5.6% 312
25.0% 3,122

18.0% 2,162
5.5% 217
24.1% 1,945

21.3% 900
6.1% 72
27.2% 828

20.7% 372
4.9% 22
26.0% 350

0.000
0.489
0.003

104 (53)
99 (51)
104 (53)

113 (54)
103 (53)
114 (54)

115 (57)
106 (51)
115 (57)

0.000
0.784
0.000

6.5%
62.8%
30.7%
5.1%
6.3%
3.7%
2.7%
3.8%
2.8%
1.9%
1.6%
0.3%
2.7%

6.3%
61.4%
32.2%
5.0%
7.1%
4.4%
2.7%
4.4%
2.4%
2.1%
1.3%
0.4%
2.5%

7.7%
59.7%
32.6%
6.8%
6.7%
4.7%
2.1%
4.2%
3.3%
1.9%
1.3%
0.3%
1.6%

Change in Pain Scores (n=12,472)
worsening
no change
pain reduction
pain reduction 10-19%
pain reduction 20-29%
pain reduction 30-39%
pain reduction 40-49%
pain reduction 50-59%
pain reduction 60-69%
pain reduction 70-79%
pain reduction 80-89%
pain reduction 90-99%
pain reduction 100%

6.6%
62.1%
31.3%
5.2%
6.5%
4.0%
2.6%
4.0%
2.7%
1.9%
1.5%
0.3%
2.5%

822
7,749
3,901
652
813
495
325
499
340
241
185
39
312

526
5,072
2,479
409
508
297
215
309
223
153
127
23
215

* only fentanyl was included as 97% of patients that received pain meds received fentanyl
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193
1,873
983
152
215
135
82
134
73
63
41
12
76

1,793
447
1,346
60
125
309
852

sig

18,000
30.7% 5,528
69.3% 12,472
9.0% 1,119
13.3% 1,655
23.4% 2,915
54.4% 6,783

107 (54)
101 (51)
108 (54)

10%
24.9%
75.1%
4.5%
9.3%
23.0%
63.3%

n

Total
Patients without Pain Screening
Patients with Pain Screening
no pain (0)
mild pain (1-3)
moderate pain (4-6)
severe pain (7-10)

Total Fentanyl Dose Admin, mcg (mean, SD)*
patients without pain screening
patients with pain screening

4,220
1,171
3,049
203
389
714
1,743

Severely Obese
(BMI > 39)

103
804
439
91
90
63
28
56
44
25
17
4
21

0.000
0.000
0.000
0.000
0.002
0.103
0.000

0.237
0.066
0.155
0.028
0.336
0.071
0.438
0.374
0.247
0.823
0.526
0.653
0.057

TableTable
3-3:3-3:
Multivariable
Logistic
Regression
Obesity
Status on
Multivariable Logistic
Regression
of Obesity of
Status
on Pain Screening
(fullPain
table) Screening
Model 1
Regressor

Model 2

Model 3

B

OR

B

OR

B

OR

0.22
0.25

1.24***
1.29***

0.36
0.39

1.44***
1.47***

0.23
0.24

1.26***
1.27***

0.19

1.20***

0.26
-0.27
-0.22

1.30***
0.76**
0.81

0.19

1.21***

-0.16
-0.28
-0.26
-0.48
-0.17

0.85
0.76
0.77**
0.62***
0.84

-0.16
-0.29
-0.26
-0.47
-0.17

0.85
0.75
0.77**
0.62***
0.84

-0.17
-0.40
-0.19
-0.46
-0.40

0.84
0.67
0.83
0.63***
0.67

0.01

0.99***

0.01

0.99***

0.01

0.99***

Private
Medicare
Medicaid
Other Government
No Insurance
Unknown Insurance

-0.11
-0.29
0.17
-0.17
-0.72

0.90
0.75**
1.18
0.85**
0.49***

-0.11
-0.29
0.17
-0.17
-0.72

0.90
0.75**
1.18
0.85**
0.49***

-0.11
-0.29
0.17
-0.16
-0.72

0.90
0.75**
1.19
0.85**
0.49***

Tramuatic Injury
Abdominal Pain
Back and Body Pain
Pain Mangement

0.87
0.88
1.72

2.38***
2.42***
5.57***

0.87
0.88
1.72

2.38***
2.41***
5.58***

0.87
0.88
1.72

2.38***
2.42***
5.57***

0.03
-0.06
-0.84

1.04
0.94
0.43***

0.03
-0.06
-0.84

1.04
0.94
0.43***

0.03
-0.06
-0.85

1.03
0.94
0.43***

0.08
-0.05
1.04
0.57
-0.29
0.17
-0.09
0.00
0.75
0.56

1.08
0.95
2.84
1.76
0.75
1.19
0.92
1.00
2.13
1.75

Not Obese
Obese (BMI 30-39)
Severely Obese (BMI >39)
Female
Female X Obese
Female X Severely Obese
White
Black
Asian
Hispanic
Other
Unknown
Age

2017 encounter
2018 encounter
2019 encounter
Black X Obese
Black X Severely Obese
Asian X Obese
Asian X Severely Obese
Hispanic X Obese
Hispanic X Severely Obese
Other Race X Obese
Other Race X Severely Obese
Unknown Race X Obese
Unknown Race X Severely Obese
Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

0.812
18,000
20,411
0.135

0.812
18,000
20,399
0.135

Note: B = logistic regression coefficient and OR=odds ratio
* p< .05, ** p< .01, *** p< .001
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0.812
18,000
20,399
0.135

3-4:Multivariate
Multivariable Logistic
Regression
of Obesity Status
Pain Medication
Administration
(full table)
TableTable
3-4:
Logistic
Regression
of on
Obesity
Status
on Pain Medication
Model 1
Regressor

Administration
Not Obese
Obese (BMI 30-39)
Severely Obese (BMI >39)
Female
Female X Obese
Female X Severely Obese
White
Black
Asian
Hispanic
Other
Unknown

B

Model 2
OR

B

Model 3
OR

B

OR

0.11
-0.01

1.11*
0.99

0.23
0.26

1.25**
1.29*

0.11
0.26

1.12
1.02

0.05

1.06

0.15
-0.21
-0.41

1.16**
0.81*
0.67**

0.06

1.06

0.82
0.95
0.68**
0.99
0.56

-0.16
-0.02
-0.39
0.02
-0.59

0.85
0.99
0.68*
1.02
0.56

-0.20
-0.04
-0.39
-0.01
-0.59

0.82
0.96
0.68**
0.99
0.56*

0.00

1.00***

0.00

1.00***

0.00

1.00***

Private
Medicare
Medicaid
Other Government
No Insurance
Unknown Insurance

-0.29
-0.75
-0.14
-0.15
-0.59

0.75***
0.47***
0.87
0.86*
0.55***

-0.29
-0.74
-0.14
-0.15
-0.59

0.75***
0.48***
0.87
0.86*
0.55***

-0.29
-0.75
-0.14
-0.14
-0.59

0.75***
0.47***
0.87
0.87*
0.56***

Tramuatic Injury
Abdominal Pain
Back and Body Pain
Pain Mangement

-0.29
-1.05
0.54

0.75***
0.35***
1.71***

-0.29
-1.06
0.54

0.75***
0.35***
1.71***

-0.30
-1.05
0.53

0.75***
0.35***
1.71***

2017 encounter
2018 encounter
2019 encounter

-0.07
0.08
0.27

0.94
1.08
1.31***

-0.06
0.08
0.27

0.94
1.09
1.32***

-0.07
0.08
0.27

0.94
1.08
1.31***

Pain Screening

33.09

0.00

33.09

0.00

33.12

0.00

Age

Initial Pain Score

0.34

1.40***

-0.20
-0.05
-0.39
-0.01
-0.58

0.34

1.40***

Black X Obese
Black X Severely Obese
Asian X Obese
Asian X Severely Obese
Hispanic X Obese
Hispanic X Severely Obese
Other Race X Obese
Other Race X Severely Obese
Unknown Race X Obese
Unknown Race X Severely Obese
Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)
Note: B = logistic regression coefficient and OR=odds ratio
* p< .05, ** p< .01, *** p< .001

0.34
-0.19
0.03
0.30
-19.99
0.10
-0.32
-0.05
-0.17
-0.06
0.17

-1.445
18,000
14,367
0.260
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-1.445
18,000
14,357
0.261

1.40***
0.82
1.03
1.34
0.00
1.11
0.73
0.96
0.84
0.94
1.18

-1.445
18,000
14,360
0.260

Table
Multivariate
Multinomial
Regression
of(fullObesity
Status on Pain Outcomes
Table3-5:
3-5: Multivariable
Multinomial Regression
of Obesity Status
on Pain Outcomes
table)
Model 1
Increased pain
Decreased Pain
Regressor

B

Not Obese
Obese (BMI 30-39)
Severely Obese (BMI >39)
Female
Female X Obese
Female X Severely Obese

OR

B

0.00
0.32

1.01
1.38*

-0.07
-0.25

0.00

1.00

OR

Model 2
Increased pain
Decreased Pain
B

B

OR

0.94
0.96

-0.05
0.548

0.96
1.73**

0.01

1.01

0.02
0.10
-0.36

1.02
1.10
0.70

0.11
-0.28
-0.28

1.12
0.75**
0.76

0.00

1.27
0.94
1.04
0.92
0.69

-0.04
-0.53
-0.08
-0.48
-0.23

0.96
0.59
0.92
0.62***
0.80

0.24
-0.06
0.04
-0.08
-0.37

1.267
0.941
1.035
0.93
0.692

0.03
-0.43
-0.24
-0.52
-0.95

0.09
0.15

OR

Model 3
Increased pain
Decreased Pain

1.10
1.17

B

-0.03
0.33

OR

B

0.967
1.39**

-0.05
-0.06

0.953
0.942

0.01

1.01

1.03
0.65
0.79
0.60**
0.39

0.04
0.11
-0.01
-0.05
-0.19

1.04
1.12
1.00
0.96
0.83

1.00

OR

White
Black
Asian
Hispanic
Other
Unknown

-0.03
-0.53
-0.08
-0.48
-0.23

0.97
0.59
0.93
0.62***
0.80

0.24
-0.06
0.04
-0.09
-0.37

Age

-0.01

0.99***

0.00

0.00**

-0.01

0.99***

0.00

0.00**

-0.01

0.99***

0.00

0.00**

Private
Medicare
Medicaid
Other Government
No Insurance
Unknown Insurance

-0.28
-0.45
0.07
-0.05
-0.80

0.76*
0.64**
1.07
0.95
0.45***

-0.06
-0.48
-0.14
-0.27
-0.39

0.94
0.62***
0.87
0.76***
0.68***

-0.28
-0.45
0.07
-0.05
-0.80

0.76*
0.64**
1.07
0.95
0.45***

-0.06
-0.47
-0.14
-0.27
-0.39

0.94
0.62***
0.87
0.76***
0.68***

-0.28
-0.45
0.07
-0.06
-0.80

0.76*
0.64**
1.08
0.94
0.45***

-0.06
-0.48
-0.14
-0.28
-0.39

0.94
0.62***
0.87
0.76***
0.68***

Tramuatic Injury
Abdominal Pain
Back and Body Pain
Pain Mangement

0.08
0.09
0.72

1.09
1.10
2.05***

0.16
-0.13
0.43

1.18*
0.88
1.54***

0.08
0.09
0.72

1.09
1.10
2.05***

0.16
-0.13
0.43

1.18*
0.879
1.54***

0.09
0.09
0.72

1.09
1.10
2.05***

0.16
-0.13
0.43

1.17**
0.879
1.54***

2017 encounter
2018 encounter
2019 encounter

0.07
0.15
0.29

1.07
1.16
1.34**

0.07
0.15
0.29

1.07
1.16
1.34**

0.07
0.15
0.29

1.073
1.16
1.34**

0.10
-0.01
0.26

0.91
0.99
1.29***

0.07
0.15
0.29

1.073
1.16
1.34**

-0.10
-0.01
0.26

0.91
0.99
1.29**

Initial Pain Score

-0.15

0.86***

0.18

1.20***

-0.15

0.86***

0.18

1.20***

-0.15

0.86***

0.18

1.20***

1.04

2.84***

2.63

13.82***

1.04

2.84***

2.63

13.80***

1.05

2.85***

2.63

13.87***

Pain Medication Admin
Black X Obese
Black X Severely Obese
Asian X Obese
Asian X Severely Obese
Hispanic X Obese
Hispanic X Severely Obese
Other Race X Obese
Other Race X Severely Obese
Unknown Race X Obese
Unknown Race X Severely Obese
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

-0.17
-0.09
-19.13
1.06
0.41
0.31
0.27
-0.50
1.38
0.84
12,472
15,726
0.404

12,472
15,716
0.405

Note: B = regression coefficient and OR=odds ratio
* p< .05, ** p< .01, *** p< .001
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0.84
0.92
0.00
2.89
1.50
1.36
1.32
0.61
3.97
2.32

0.29
0.51
-1.11
-0.20
-0.02
0.30
-0.15
0.03
-0.37
-0.46
12,472
15,711
0.405

1.337
1.659
0.33
0.815
0.984
1.349
0.859
1.026
0.688
0.635

Table 4-1: Social / Demographic Characteristics
Table 4-1: Social / Demographic Characteristics
All Patients
Total
Age (mean, SD)

Patients with
LEP
without

without LEP
57693 98.0%

with LEP
1155 2.0%

sig
-

with Interpreter
559 48.4%

56, 22

58, 21

0.006

61, 20

Interpreter
596 51.6%
55, 20

sig
<.001

Female

27317

47%

596

52%

0.004

337

60%

259

43%

<.001

White
Black
Asian
Hispanic
Other
Unknown

35208
4036
955
1919
2324
13251

61%
7%
2%
3%
4%
23%

162
32
243
330
97
291

14%
3%
21%
29%
8%
25%

<.001
<.001
0.000
0.000
<.001
0.075

86
11
129
158
50
125

15%
2%
23%
28%
9%
22%

76
21
114
172
47
166

13%
4%
19%
29%
8%
28%

0.198
0.108
0.100
0.823
0.517
0.032

Private
Medicare
Medicaid
Other Govt
Worker's Comp
Unknown
No Insurance

10646
7847
11767
1357
170
8689
17217

18%
14%
20%
2%
0%
15%
30%

81
82
254
0
7
113
618

7%
7%
22%
0%
1%
10%
54%

<.001
<.001
0.183
<.001
0.056
<.001
<.001

38
52
127
0
2
70
270

7%
9%
23%
0%
0%
13%
48%

43
30
127
0
5
43
348

7%
5%
21%
0%
1%
7%
58%

0.782
0.005
0.563
0.293
0.002
<.001

98

99
9%
2%
13%

5323
539
4784

Patients without Pain Screening
Patients with Pain Screening
no pain (0)
mild pain (1-4)
moderate pain (5-8)
severe pain (9-10)

Pain Medication Admin Rate Overall (n=57,693)
patients without pain screening (n=21,705)
patients with pain screening (n=35,988)

78
34
44

750
405
45
81
172
107

38%
62%
11%
23%
41%
25%

21705
35988
4058
8197
14765
8968

Total

7%
5%
11%

65%
35%
11%
20%
42%
26%

with LEP
1155
2.0%

All Patients
without LEP
57693
98.0%

Table 4-2: Clinical Characteristics

0.004
<.001
0.152

<.001
<.001
0.917
0.185
0.558
0.488

sig
-

42
16
26

344
215
25
42
91
57

8%
5%
12%

62%
38%
12%
20%
42%
27%

with Interpreter
559
48.4%

36
18
18

406
190
20
39
81
50

6%
4%
9%

68%
32%
11%
21%
43%
26%

without Interpreter
596
51.6%

Patients with LEP

0.319
0.887
0.399

0.019
0.019
0.726
0.804
0.951
0.965

sig
-

Table 4-2: Clinical Characteristics

TableTable
4-3: 4-3:
Types
of Interpreter
Solutions
LEP
Types
of Interpreter
Solutionsfor
forPatients
Patients with
with LEP
LEP Cases

1155

100.0%

No Interpreter Used
Interpreter Solution Used*

596
559

51.6%
48.4%

Family or Friends
Bystander
Interpreter Used from Unknown Source
Official Interpreter Resource (Language Line or Fire Depart.)
EMS Crew Member Informal Interpreter
Informal Tech Tools (Google translate, etc.)
* some cases charted multiple interpreter solutions

337
113
51
31
22
7

60.3%
20.2%
9.1%
5.5%
3.9%
1.3%
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Table 4-4: Multivariable Logistic Regression on Pain Screening
Table 4-4: Multivariable Logistic Regression on Pain Screening
Model 1
Regressor
Non-LEP (ref)
LEP
LEP w/ Interpreter
LEP w/o Interpreter
White
Black
Asian
Hispanic
Other
Unknown

B

-1.03

0.06
-0.49
-0.01
-0.08
-0.14

Model 2
OR

0.36***

1.06
0.61***
1.01
0.93
0.87***

B

-1.00

Model 3
OR

B

Model 4
OR

B

OR

0.37***
-0.87
-1.15

0.42***
0.31***

-0.82
-1.18

0.44***
0.31***

0.06
-0.49
0.01
-0.08
-0.13

1.06
0.61***
1.00
0.93
0.87***

-0.06
-0.50
-0.11
-0.07
-0.10

0.94
0.61***
0.89*
0.93
0.90***

-0.06
-0.49
-0.11
-0.07
-0.10

0.94
0.61***
0.89*
0.93
0.90***

0.22

1.24***

0.22

1.24***

Age (years)

-0.01

0.99***

-0.01

0.99***

Private Insurance
Medicare
Medicaid
Other Government
Workers Comp
No Insurance
Unknown Insurance

-0.14
-0.19
-0.21
0.73
-0.33
-0.90

0.87***
0.83***
0.81***
2.07***
0.72***
0.41***

-0.14
-0.19
-0.22
0.73
-0.33
-0.90

0.87***
0.83***
0.81***
2.08***
0.72***
0.41***

0.01

1.01***

0.01

1.01***

-0.05

0.95***

-0.05

0.95***

Female

Primary Impression Category
Incident year
Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

0.483
58,848
77,793
0.010

0.483
58,848
76,057
0.050

Note: B = logistic regression coefficient and OR=odds ratio
* p< .05, ** p< .01, *** p< .001
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0.483
58,848
77,787
0.011

0.483
58,848
76,022
0.050

Table 4-5: Multivariable Logistic Regression on Pain Medication Administration
Table 4-5: Multivariable Logistic Regression on Pain Screening
Model 1 #
Regressor
Not LEP (ref)
LEP
LEP w/ Interpreter
LEP w/o Interpreter

B

-0.27

OR

Model 2 #
B

OR

-0.12
-0.41

Constant
Number of Cases
-2 log likelihood
Pseudo R2 (Nagelkerke)

-0.21
-0.28
-0.11
-0.24
0.03

B

OR

0.77*
0.89
0.66*

Pain Screening
White
Black
Asian
Hispanic
Other
Unknown

Model 3 #

0.81***
0.75*
0.89
0.79**
1.03

-2.29
58,848
35,408
0.025

-0.21
-0.29
-0.11
-0.24
0.03

0.81***
0.75*
0.89
0.79**
1.03

-2.29
58,848
35,407
0.025

0.19
0.04

1.21
1.04

1.71

5.52***

-0.20
-0.13
-0.10
-0.22
0.07

0.82**
0.88
0.91
0.80**
1.07

-2.29
58,848
35,400
0.025

Note: B = logistic regression coefficient and OR=odds ratio
* p< .05, ** p< .01, *** p< .001
# - Model adjusts for: patient gender, patient age, patient health insurance, primary impression, and year
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